| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH4 ERCC6 ATRX KIF28P ATP13A3 ABCD1 HSPA1A DNAH5 HSPA1B KIF17 HSPA1L HSPA2 HSPA8 DNAH2 KIF20A FBH1 EIF4A2 ATP5F1A | 3.04e-07 | 441 | 193 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH4 ERCC6 ATRX RASL12 GIMAP7 KIF28P ATP13A3 ABCD1 HSPA1A DNAH5 HSPA1B KIF17 HSPA1L HSPA2 HSPA8 RRAS2 DNAH2 RAB44 KIF20A FBH1 EIF4A2 ATP5F1A | 6.32e-06 | 775 | 193 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH4 ERCC6 ATRX KIF28P ATP13A3 ABCD1 HSPA1A DNAH5 HSPA1B KIF17 HSPA1L HSPA2 HSPA8 DNAH2 DNAH1 KIF20A FBH1 EIF4A2 ATP5F1A | 8.48e-06 | 614 | 193 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.74e-05 | 6 | 193 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.74e-05 | 6 | 193 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH4 ERCC6 ATRX RASL12 GIMAP7 KIF28P ATP13A3 ABCD1 HSPA1A DNAH5 HSPA1B KIF17 HSPA1L HSPA2 HSPA8 RRAS2 DNAH2 RAB44 KIF20A FBH1 EIF4A2 ATP5F1A | 2.16e-05 | 839 | 193 | 22 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH4 ERCC6 ATRX RASL12 GIMAP7 KIF28P ATP13A3 ABCD1 HSPA1A DNAH5 HSPA1B KIF17 HSPA1L HSPA2 HSPA8 RRAS2 DNAH2 RAB44 KIF20A FBH1 EIF4A2 ATP5F1A | 2.20e-05 | 840 | 193 | 22 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH4 ERCC6 ATRX RASL12 GIMAP7 KIF28P ATP13A3 ABCD1 HSPA1A DNAH5 HSPA1B KIF17 HSPA1L HSPA2 HSPA8 RRAS2 DNAH2 RAB44 KIF20A FBH1 EIF4A2 ATP5F1A | 2.20e-05 | 840 | 193 | 22 | GO:0016818 |
| GeneOntologyMolecularFunction | heat shock protein binding | 3.04e-05 | 163 | 193 | 9 | GO:0031072 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 4.00e-05 | 40 | 193 | 5 | GO:0140662 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.92e-05 | 70 | 193 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.51e-04 | 118 | 193 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 2.77e-04 | 3 | 193 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | denatured protein binding | 2.77e-04 | 3 | 193 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 3.71e-04 | 15 | 193 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 5.51e-04 | 4 | 193 | 2 | GO:0047042 | |
| GeneOntologyMolecularFunction | phosphopyruvate hydratase activity | 5.51e-04 | 4 | 193 | 2 | GO:0004634 | |
| GeneOntologyMolecularFunction | histone pre-mRNA DCP binding | 5.51e-04 | 4 | 193 | 2 | GO:0071208 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 5.51e-04 | 4 | 193 | 2 | GO:0045703 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 5.51e-04 | 4 | 193 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 5.51e-04 | 4 | 193 | 2 | GO:0047743 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 6.52e-04 | 18 | 193 | 3 | GO:0051787 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 6.52e-04 | 18 | 193 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 7.07e-04 | 73 | 193 | 5 | GO:0044183 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 7.78e-04 | 43 | 193 | 4 | GO:0030280 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | GPHN IRAK1 ERVK-10 JAK1 NEK1 MED21 FGR ROCK2 POLG ADCK1 SIK3 POLR3A NRBP2 FLAD1 AGK ATM MAPK6 MAPK11 EIF2AK2 EPHA1 | 7.83e-04 | 938 | 193 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 9.12e-04 | 5 | 193 | 2 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 9.12e-04 | 5 | 193 | 2 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 9.12e-04 | 5 | 193 | 2 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 9.12e-04 | 5 | 193 | 2 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 9.12e-04 | 5 | 193 | 2 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 9.12e-04 | 5 | 193 | 2 | GO:0047086 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 9.12e-04 | 5 | 193 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 9.12e-04 | 5 | 193 | 2 | GO:0047787 | |
| GeneOntologyMolecularFunction | DNA translocase activity | 9.12e-04 | 5 | 193 | 2 | GO:0015616 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 9.55e-04 | 78 | 193 | 5 | GO:0003725 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GPHN MYH4 ADGRV1 NEB NME8 IQGAP1 DST STMN3 NFKB1 KIF28P KIF17 HSPA2 ROCK2 DPYSL3 IFT74 JAKMIP3 KIF20A MAP1S FARP1 ARHGEF2 DMTN MYBPC3 | 9.80e-04 | 1099 | 193 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | ubiquitin ligase complex scaffold activity | 1.36e-03 | 6 | 193 | 2 | GO:0160072 | |
| GeneOntologyMolecularFunction | dihydropyrimidinase activity | 1.36e-03 | 6 | 193 | 2 | GO:0004157 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.36e-03 | 6 | 193 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 1.89e-03 | 7 | 193 | 2 | GO:0072582 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.44e-03 | 28 | 193 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.50e-03 | 8 | 193 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 2.50e-03 | 8 | 193 | 2 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 2.50e-03 | 8 | 193 | 2 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 3.20e-03 | 9 | 193 | 2 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 3.20e-03 | 9 | 193 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 3.65e-03 | 152 | 193 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.92e-03 | 33 | 193 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 3.97e-03 | 10 | 193 | 2 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 3.97e-03 | 10 | 193 | 2 | GO:0032052 | |
| GeneOntologyBiologicalProcess | microtubule-based process | STAG1 ATRX NME8 NEFL DST STMN3 KIF28P TACC3 HSPA1A DNAH5 HSPA1B KIF17 HSPA8 ZMYND12 ROCK2 IFT74 DNAH2 SIK3 DNAH1 KIF20A WDR19 CCNF AKAP9 MAP1S PDE4DIP TMF1 ARHGEF2 | 1.54e-06 | 1058 | 190 | 27 | GO:0007017 |
| GeneOntologyBiologicalProcess | protein refolding | 7.44e-06 | 30 | 190 | 5 | GO:0042026 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | NEB IQGAP1 NEFL FCHSD2 STMN3 TACC3 HSPA1A HSPA1B HSPA8 ROCK2 DPYSL3 KRT12 KRT81 KRT83 KRT85 KRT86 AKAP9 MAP1S PDE4DIP TENM1 ARHGEF2 DMTN EPHA1 MYBPC3 | 8.34e-06 | 957 | 190 | 24 | GO:0097435 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | STAG1 ATRX NEFL DST STMN3 TACC3 HSPA1A DNAH5 HSPA1B ZMYND12 ROCK2 DNAH2 SIK3 DNAH1 KIF20A CCNF AKAP9 MAP1S PDE4DIP ARHGEF2 | 1.17e-05 | 720 | 190 | 20 | GO:0000226 |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 1.63e-05 | 35 | 190 | 5 | GO:0051085 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 1.70e-05 | 88 | 190 | 7 | GO:0071277 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 3.60e-05 | 41 | 190 | 5 | GO:0051084 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 3.67e-05 | 99 | 190 | 7 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 3.92e-05 | 100 | 190 | 7 | GO:0045103 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 4.16e-05 | 8 | 190 | 3 | GO:0090063 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | NME8 NEFL DST KIF28P DNAH5 KIF17 HSPA8 ZMYND12 IFT74 DNAH2 DNAH1 KIF20A WDR19 MAP1S TMF1 | 5.51e-05 | 493 | 190 | 15 | GO:0007018 |
| GeneOntologyBiologicalProcess | protein-containing complex localization | GPHN AP2B1 IQSEC1 MIOS KIF17 IFT74 LMNB2 RALGAPA2 WDR19 AKAP9 ATM | 5.66e-05 | 278 | 190 | 11 | GO:0031503 |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial fusion | 6.20e-05 | 9 | 190 | 3 | GO:0010637 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 6.35e-05 | 46 | 190 | 5 | GO:0006458 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 6.41e-05 | 108 | 190 | 7 | GO:0031110 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 6.71e-05 | 75 | 190 | 6 | GO:0045109 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 8.80e-05 | 10 | 190 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | chaperone-mediated protein folding | 9.64e-05 | 80 | 190 | 6 | GO:0061077 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | NEB FCHSD2 STMN3 FGR TACC3 HSPA1A HSPA1B ROCK2 CCNF AKAP9 MAP1S PDE4DIP TENM1 ARHGEF2 DMTN EPHA1 | 9.64e-05 | 579 | 190 | 16 | GO:0051493 |
| GeneOntologyBiologicalProcess | positive regulation of stem cell population maintenance | 1.05e-04 | 51 | 190 | 5 | GO:1902459 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 1.24e-04 | 253 | 190 | 10 | GO:0099111 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 1.26e-04 | 53 | 190 | 5 | GO:0071320 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | PDE6C ERCC6 PDE1B ACADL ACTR5 IRAK1 ADGRV1 ITPR1 ITPR2 NEK1 NFKB1 SCN7A TACC3 HSPA1A HSPA1B HSPA2 SLC25A23 HSPA8 CUL4B ROCK2 CACNA1F TFRC AKAP9 ATM ARHGEF2 MAPK11 DNAJC3 | 1.34e-04 | 1361 | 190 | 27 | GO:0009628 |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 1.59e-04 | 12 | 190 | 3 | GO:0090084 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | HCN2 AKR1C1 AKR1C2 ADCY6 ITPR1 ITPR2 NFKB1 HSPA1A HSPA1B HSPA8 ROCK2 SIN3A AKAP9 TMF1 ATP5F1A DMTN | 1.59e-04 | 605 | 190 | 16 | GO:0071407 |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 2.03e-04 | 219 | 190 | 9 | GO:0071248 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 2.33e-04 | 176 | 190 | 8 | GO:0070507 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 2.92e-04 | 35 | 190 | 4 | GO:0099188 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression via chromosomal CpG island demethylation | 3.23e-04 | 15 | 190 | 3 | GO:0044029 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | IQGAP1 FCHSD2 IQSEC1 HSPA1A HSPA1B ROCK2 DPYSL3 ADGRL1 TFRC AKAP9 PDE4DIP TENM1 ATM EPHA1 PLCE1 | 3.37e-04 | 582 | 190 | 15 | GO:0044089 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | STAG1 GINS1 IQGAP1 TACC3 EXOC7 HSPA1A HSPA1B HSPA2 HSPA8 CUL4B ROCK2 CUL2 CUL1 SIN3A KIF20A CCNF MAP1S ATM ARHGEF2 | 3.56e-04 | 854 | 190 | 19 | GO:1903047 |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization | 3.63e-04 | 37 | 190 | 4 | GO:0031116 | |
| GeneOntologyBiologicalProcess | positive regulation of protein polymerization | 3.65e-04 | 102 | 190 | 6 | GO:0032273 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 3.94e-04 | 16 | 190 | 3 | GO:0032351 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | STMN3 TACC3 HSPA1A HSPA1B ROCK2 CCNF AKAP9 MAP1S PDE4DIP ARHGEF2 | 4.04e-04 | 293 | 190 | 10 | GO:0032886 |
| GeneOntologyBiologicalProcess | regulation of mitochondrial fusion | 4.76e-04 | 17 | 190 | 3 | GO:0010635 | |
| GeneOntologyBiologicalProcess | positive regulation of supramolecular fiber organization | 4.80e-04 | 196 | 190 | 8 | GO:1902905 | |
| GeneOntologyBiologicalProcess | transport along microtubule | 4.96e-04 | 197 | 190 | 8 | GO:0010970 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 5.00e-04 | 4 | 190 | 2 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 5.00e-04 | 4 | 190 | 2 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 5.00e-04 | 4 | 190 | 2 | GO:0008208 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 5.00e-04 | 4 | 190 | 2 | GO:0071395 | |
| GeneOntologyBiologicalProcess | positive regulation of NF-kappaB transcription factor activity | 5.09e-04 | 151 | 190 | 7 | GO:0051092 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 5.67e-04 | 18 | 190 | 3 | GO:0030656 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization or depolymerization | 5.94e-04 | 42 | 190 | 4 | GO:0031112 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | FCHSD2 HSPA1A HSPA1B HSPA8 VPS8 TFRC AKAP9 PDE4DIP TENM1 ATM ARHGEF2 EIF2AK2 DMTN | 6.30e-04 | 489 | 190 | 13 | GO:0043254 |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | 6.45e-04 | 205 | 190 | 8 | GO:0051495 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | CLEC1B ITGA1 STRIP2 IQGAP1 ITPR1 NEFL DST FGR NOTCH2 ROCK2 CACNA1F CPNE9 SIN3A NIBAN2 THOC5 WDR19 ARHGAP4 MAP1S FARP1 TET1 ARHGEF2 CDH7 DMTN | 6.55e-04 | 1194 | 190 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of microtubule nucleation | 6.69e-04 | 19 | 190 | 3 | GO:0010968 | |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 7.09e-04 | 208 | 190 | 8 | GO:0009266 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 7.45e-04 | 161 | 190 | 7 | GO:0051592 | |
| GeneOntologyBiologicalProcess | neuron projection development | ERCC6 ITGA1 ADGRV1 ADCY6 IQGAP1 ITPR1 NEFL DST STMN3 IQSEC1 NOTCH2 CUL4B ROCK2 CACNA1F DPYSL2 DPYSL3 CPNE9 SIN3A NIBAN2 ARHGAP4 MAP1S FARP1 TET1 MAPK6 | 7.68e-04 | 1285 | 190 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 7.71e-04 | 78 | 190 | 5 | GO:2000036 | |
| GeneOntologyBiologicalProcess | cellular response to chemical stress | NME8 SCN7A ABCD1 HSPA1A HSPA1B SLC25A23 HSPA8 SIN3A TET1 ATM ARHGEF2 | 7.76e-04 | 377 | 190 | 11 | GO:0062197 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | FCHSD2 HSPA1A HSPA1B HSPA8 ROCK2 AKAP9 MAP1S PDE4DIP TENM1 ARHGEF2 DMTN EPHA1 | 7.83e-04 | 438 | 190 | 12 | GO:1902903 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH4 FRMPD4 NEB IQGAP1 FCHSD2 SCN7A IQSEC1 FGR ROCK2 DPYSL3 AKAP9 HMCN1 FARP1 TENM1 ARHGEF2 ACAP2 DMTN EPHA1 MYBPC3 | 7.90e-04 | 912 | 190 | 19 | GO:0030029 |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 8.29e-04 | 5 | 190 | 2 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 8.29e-04 | 5 | 190 | 2 | GO:0120256 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 8.29e-04 | 5 | 190 | 2 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 8.29e-04 | 5 | 190 | 2 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 8.29e-04 | 5 | 190 | 2 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 8.29e-04 | 5 | 190 | 2 | GO:1900053 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound catabolic process | 8.41e-04 | 46 | 190 | 4 | GO:0072529 | |
| GeneOntologyBiologicalProcess | response to heat | 9.03e-04 | 121 | 190 | 6 | GO:0009408 | |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 9.06e-04 | 21 | 190 | 3 | GO:0090083 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 9.06e-04 | 21 | 190 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 9.15e-04 | 81 | 190 | 5 | GO:0034605 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | IQGAP1 NEFL DST KIF28P DNAH5 KIF17 HSPA8 DPYSL2 DPYSL3 KRT12 KRT81 KRT83 KRT85 KRT86 DNAH2 LMNB2 DNAH1 KIF20A ARHGAP4 MAP1S PDE4DIP ARHGEF2 DMTN | 1.93e-05 | 899 | 201 | 23 | GO:0099513 |
| GeneOntologyCellularComponent | COP9 signalosome | 3.03e-05 | 38 | 201 | 5 | GO:0008180 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 5.51e-05 | 137 | 201 | 8 | GO:0019897 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH4 NEB IQGAP1 NEFL DST KIF28P DNAH5 KIF17 HSPA8 DPYSL2 DPYSL3 KRT12 KRT81 KRT83 KRT85 KRT86 DNAH2 LMNB2 DNAH1 KIF20A ARHGAP4 MAP1S PDE4DIP ARHGEF2 DMTN MYBPC3 | 6.76e-05 | 1179 | 201 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 7.05e-05 | 9 | 201 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | supramolecular polymer | MYH4 NEB IQGAP1 NEFL DST KIF28P DNAH5 KIF17 HSPA8 DPYSL2 DPYSL3 KRT12 KRT81 KRT83 KRT85 KRT86 DNAH2 LMNB2 DNAH1 KIF20A ARHGAP4 MAP1S PDE4DIP ARHGEF2 DMTN MYBPC3 | 7.55e-05 | 1187 | 201 | 26 | GO:0099081 |
| GeneOntologyCellularComponent | axonemal dynein complex | 8.96e-05 | 25 | 201 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.37e-04 | 11 | 201 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.70e-04 | 161 | 201 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 3.44e-04 | 35 | 201 | 4 | GO:0099243 | |
| GeneOntologyCellularComponent | intermediate filament | 3.64e-04 | 227 | 201 | 9 | GO:0005882 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 4.01e-04 | 230 | 201 | 9 | GO:0019898 | |
| GeneOntologyCellularComponent | postsynaptic density | GPHN FRMPD4 ITPR1 DST IQSEC1 TACC3 HSPA8 ROCK2 DPYSL2 CNKSR2 AKAP9 ARHGEF2 DMTN | 4.45e-04 | 451 | 201 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | phosphopyruvate hydratase complex | 5.45e-04 | 4 | 201 | 2 | GO:0000015 | |
| GeneOntologyCellularComponent | growth cone | 6.32e-04 | 245 | 201 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | microtubule | IQGAP1 DST KIF28P DNAH5 KIF17 HSPA8 DPYSL2 DNAH2 DNAH1 KIF20A ARHGAP4 MAP1S PDE4DIP ARHGEF2 | 6.77e-04 | 533 | 201 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | asymmetric synapse | GPHN FRMPD4 ITPR1 DST IQSEC1 TACC3 HSPA8 ROCK2 DPYSL2 CNKSR2 AKAP9 ARHGEF2 DMTN | 7.50e-04 | 477 | 201 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | site of polarized growth | 7.94e-04 | 253 | 201 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.04e-03 | 263 | 201 | 9 | GO:0045111 | |
| GeneOntologyCellularComponent | distal axon | IQGAP1 NEFL STMN3 GLUL EXOC7 HSPA8 DPYSL2 DPYSL3 POLG ADGRL1 ARHGAP4 ENO2 | 1.07e-03 | 435 | 201 | 12 | GO:0150034 |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 1.18e-03 | 22 | 201 | 3 | GO:0098890 | |
| GeneOntologyCellularComponent | Sin3-type complex | 1.18e-03 | 22 | 201 | 3 | GO:0070822 | |
| GeneOntologyCellularComponent | postsynaptic specialization | GPHN FRMPD4 ITPR1 DST IQSEC1 TACC3 HSPA8 ROCK2 DPYSL2 CNKSR2 AKAP9 ARHGEF2 DMTN | 1.21e-03 | 503 | 201 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | periciliary membrane compartment | 1.35e-03 | 6 | 201 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | GPHN FRMPD4 ITPR1 DST IQSEC1 TACC3 HSPA8 ROCK2 DPYSL2 CNKSR2 AKAP9 ARHGEF2 DMTN | 1.72e-03 | 523 | 201 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | dynein complex | 1.80e-03 | 54 | 201 | 4 | GO:0030286 | |
| Domain | DUF1220 | 4.43e-08 | 11 | 189 | 5 | PF06758 | |
| Domain | NBPF_dom | 4.43e-08 | 11 | 189 | 5 | IPR010630 | |
| Domain | NBPF | 4.43e-08 | 11 | 189 | 5 | PS51316 | |
| Domain | HSP70 | 4.02e-07 | 16 | 189 | 5 | PF00012 | |
| Domain | HSP70_2 | 5.64e-07 | 17 | 189 | 5 | PS00329 | |
| Domain | HSP70_1 | 5.64e-07 | 17 | 189 | 5 | PS00297 | |
| Domain | HSP70_3 | 5.64e-07 | 17 | 189 | 5 | PS01036 | |
| Domain | Hsp_70_fam | 7.75e-07 | 18 | 189 | 5 | IPR013126 | |
| Domain | Intermediate_filament_CS | 3.33e-06 | 63 | 189 | 7 | IPR018039 | |
| Domain | Cullin_repeat-like_dom | 4.72e-06 | 12 | 189 | 4 | IPR016159 | |
| Domain | - | 4.72e-06 | 12 | 189 | 4 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 4.72e-06 | 12 | 189 | 4 | IPR029047 | |
| Domain | - | 6.76e-06 | 13 | 189 | 4 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 6.76e-06 | 13 | 189 | 4 | IPR018181 | |
| Domain | HSP70_C | 6.76e-06 | 13 | 189 | 4 | IPR029048 | |
| Domain | Filament | 7.48e-06 | 71 | 189 | 7 | SM01391 | |
| Domain | IF | 8.22e-06 | 72 | 189 | 7 | PS00226 | |
| Domain | Filament | 9.02e-06 | 73 | 189 | 7 | PF00038 | |
| Domain | IF | 1.18e-05 | 76 | 189 | 7 | IPR001664 | |
| Domain | Cullin_CS | 3.46e-05 | 7 | 189 | 3 | IPR016157 | |
| Domain | CULLIN | 3.46e-05 | 7 | 189 | 3 | SM00182 | |
| Domain | Cullin_neddylation_domain | 5.50e-05 | 8 | 189 | 3 | IPR019559 | |
| Domain | Cullin_Nedd8 | 5.50e-05 | 8 | 189 | 3 | PF10557 | |
| Domain | Cullin_Nedd8 | 5.50e-05 | 8 | 189 | 3 | SM00884 | |
| Domain | Cullin_homology | 8.19e-05 | 9 | 189 | 3 | IPR016158 | |
| Domain | DUF1220 | 8.19e-05 | 9 | 189 | 3 | SM01148 | |
| Domain | Keratin_2_head | 9.21e-05 | 24 | 189 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 9.21e-05 | 24 | 189 | 4 | PF16208 | |
| Domain | MoaB/Mog_dom | 1.02e-04 | 2 | 189 | 2 | IPR001453 | |
| Domain | - | 1.02e-04 | 2 | 189 | 2 | 3.40.980.10 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 1.02e-04 | 2 | 189 | 2 | IPR013037 | |
| Domain | MoCF_biosynth | 1.02e-04 | 2 | 189 | 2 | PF00994 | |
| Domain | MoCF_biosynth | 1.02e-04 | 2 | 189 | 2 | SM00852 | |
| Domain | - | 1.02e-04 | 2 | 189 | 2 | 2.60.40.1150 | |
| Domain | Cullin | 1.16e-04 | 10 | 189 | 3 | PF00888 | |
| Domain | CULLIN_2 | 1.16e-04 | 10 | 189 | 3 | PS50069 | |
| Domain | Cullin_N | 1.16e-04 | 10 | 189 | 3 | IPR001373 | |
| Domain | CULLIN_1 | 1.16e-04 | 10 | 189 | 3 | PS01256 | |
| Domain | Keratin_II | 1.28e-04 | 26 | 189 | 4 | IPR003054 | |
| Domain | TPR_REGION | 2.81e-04 | 165 | 189 | 8 | PS50293 | |
| Domain | TPR | 2.81e-04 | 165 | 189 | 8 | PS50005 | |
| Domain | Enolase_N | 3.04e-04 | 3 | 189 | 2 | PF03952 | |
| Domain | Enolase | 3.04e-04 | 3 | 189 | 2 | IPR000941 | |
| Domain | AP_complex_bsu_1_2_4 | 3.04e-04 | 3 | 189 | 2 | IPR016342 | |
| Domain | Enolase_C | 3.04e-04 | 3 | 189 | 2 | IPR020810 | |
| Domain | Enolase_N | 3.04e-04 | 3 | 189 | 2 | IPR020811 | |
| Domain | Enolase_CS | 3.04e-04 | 3 | 189 | 2 | IPR020809 | |
| Domain | InsP3_rcpt-bd | 3.04e-04 | 3 | 189 | 2 | IPR000493 | |
| Domain | Enolase_C | 3.04e-04 | 3 | 189 | 2 | PF00113 | |
| Domain | Enolase_N | 3.04e-04 | 3 | 189 | 2 | SM01193 | |
| Domain | Enolase_C | 3.04e-04 | 3 | 189 | 2 | SM01192 | |
| Domain | B2-adapt-app_C | 3.04e-04 | 3 | 189 | 2 | PF09066 | |
| Domain | ENOLASE | 3.04e-04 | 3 | 189 | 2 | PS00164 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.42e-04 | 14 | 189 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.42e-04 | 14 | 189 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.42e-04 | 14 | 189 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.42e-04 | 14 | 189 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.42e-04 | 14 | 189 | 3 | IPR011704 | |
| Domain | MT | 3.42e-04 | 14 | 189 | 3 | PF12777 | |
| Domain | AAA_8 | 3.42e-04 | 14 | 189 | 3 | PF12780 | |
| Domain | AAA_5 | 3.42e-04 | 14 | 189 | 3 | PF07728 | |
| Domain | DHC_fam | 4.24e-04 | 15 | 189 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 4.24e-04 | 15 | 189 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.24e-04 | 15 | 189 | 3 | IPR004273 | |
| Domain | - | 6.03e-04 | 4 | 189 | 2 | 3.30.390.10 | |
| Domain | - | 6.03e-04 | 4 | 189 | 2 | 3.20.20.120 | |
| Domain | B2-adapt-app_C | 6.03e-04 | 4 | 189 | 2 | SM01020 | |
| Domain | Enolase_C-like | 6.03e-04 | 4 | 189 | 2 | IPR029065 | |
| Domain | Enolase_N-like | 6.03e-04 | 4 | 189 | 2 | IPR029017 | |
| Domain | B-adaptin_app_sub_C | 6.03e-04 | 4 | 189 | 2 | IPR015151 | |
| Domain | TPR-like_helical_dom | 6.29e-04 | 233 | 189 | 9 | IPR011990 | |
| Domain | TPR-contain_dom | 8.47e-04 | 150 | 189 | 7 | IPR013026 | |
| Domain | AP_beta | 9.98e-04 | 5 | 189 | 2 | IPR026739 | |
| Domain | Glyco_hydro_38_C | 9.98e-04 | 5 | 189 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 9.98e-04 | 5 | 189 | 2 | PF09261 | |
| Domain | Glyco_hydro_57/38_cen | 9.98e-04 | 5 | 189 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38 | 9.98e-04 | 5 | 189 | 2 | PF01074 | |
| Domain | - | 9.98e-04 | 5 | 189 | 2 | 1.20.1270.50 | |
| Domain | - | 9.98e-04 | 5 | 189 | 2 | 3.20.110.10 | |
| Domain | Alpha-mann_mid | 9.98e-04 | 5 | 189 | 2 | SM00872 | |
| Domain | Glyco_hydro_38_N | 9.98e-04 | 5 | 189 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 9.98e-04 | 5 | 189 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38_cen | 9.98e-04 | 5 | 189 | 2 | IPR015341 | |
| Domain | Glyco_hydro_38C | 9.98e-04 | 5 | 189 | 2 | PF07748 | |
| Domain | Kinase-like_dom | IRAK1 JAK1 NEK1 DST FGR ROCK2 ADCK1 SIK3 NRBP2 ATM MAPK6 MAPK11 EIF2AK2 EPHA1 | 1.28e-03 | 542 | 189 | 14 | IPR011009 |
| Domain | RIH_assoc-dom | 1.49e-03 | 6 | 189 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.49e-03 | 6 | 189 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.49e-03 | 6 | 189 | 2 | PF08454 | |
| Domain | RIH_dom | 1.49e-03 | 6 | 189 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.49e-03 | 6 | 189 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.49e-03 | 6 | 189 | 2 | IPR015925 | |
| Domain | Hydantoinase/dihydroPyrase | 1.49e-03 | 6 | 189 | 2 | IPR011778 | |
| Domain | - | 1.49e-03 | 6 | 189 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.49e-03 | 6 | 189 | 2 | PF01365 | |
| Domain | Beta2_adaptin/TBP_C_dom | 1.49e-03 | 6 | 189 | 2 | IPR012295 | |
| Domain | - | 1.49e-03 | 6 | 189 | 2 | 3.30.310.10 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 2.07e-03 | 7 | 189 | 2 | IPR011330 | |
| Domain | RASGEF | 2.23e-03 | 26 | 189 | 3 | PS00720 | |
| Domain | DHC_N1 | 2.74e-03 | 8 | 189 | 2 | PF08385 | |
| Domain | Coatomer/calthrin_app_sub_C | 2.74e-03 | 8 | 189 | 2 | IPR009028 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.43e-07 | 13 | 148 | 5 | MM14952 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 3.44e-06 | 23 | 148 | 5 | MM14953 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 5.66e-06 | 66 | 148 | 7 | MM17074 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 6.34e-06 | 94 | 148 | 8 | MM14515 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 9.64e-06 | 28 | 148 | 5 | M27254 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 1.31e-05 | 136 | 148 | 9 | M42547 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.46e-05 | 76 | 148 | 7 | M48037 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.65e-05 | 52 | 148 | 6 | MM14949 | |
| Pathway | KEGG_ENDOCYTOSIS | AP2B1 IQSEC1 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 VPS37D TFRC ACAP2 | 2.10e-05 | 181 | 148 | 10 | M1519 |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.82e-05 | 57 | 148 | 6 | M27251 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 3.02e-05 | 151 | 148 | 9 | M550 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 4.53e-05 | 38 | 148 | 5 | M27255 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 9.88e-05 | 71 | 148 | 6 | M39690 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.03e-04 | 138 | 148 | 8 | MM15635 | |
| Pathway | BIOCARTA_RNA_PATHWAY | 1.29e-04 | 10 | 148 | 3 | M10570 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.20e-04 | 82 | 148 | 6 | M27250 | |
| Pathway | KEGG_SPLICEOSOME | 3.81e-04 | 127 | 148 | 7 | M2044 | |
| Pubmed | NBPF12 NBPF19 NBPF14 NBPF8 NBPF11 NBPF20 NBPF15 NBPF9 NBPF10 | 1.82e-15 | 21 | 203 | 9 | 16079250 | |
| Pubmed | USP34 STAG1 ATRX IQGAP1 JAK1 NEFL NAA25 DST AP2B1 GLUL UROD EXOC7 HSPA1A HSPA1B HSPA2 TARS1 VCPIP1 DPYSL2 IFT74 KRT83 POLG JAKMIP3 HUWE1 WDR19 FBH1 MAP1S EIF4A2 PDE4DIP NEMF COPS4 RAI14 ZNF350 ATM ATP5F1A | 1.64e-13 | 1285 | 203 | 34 | 35914814 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | PDE1B ACADL ADCY6 ITPR1 NEFL DST AP1B1 AP2B1 GLUL HSPA1B HSPA2 HSPA8 ROCK2 CUL2 DPYSL2 DPYSL3 MAN2B2 LMNB2 HUWE1 ARHGEF2 SNRPD3 ENO3 CCDC9 ATP5F1A | 3.39e-13 | 621 | 203 | 24 | 22794259 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | USP34 CDR2 ATRX USE1 IRAK1 EFCAB14 RB1CC1 ITPR2 JAK1 NEK1 DST AP1B1 AP2B1 HSPA1A HSPA1B SLC25A23 HSPA8 CUL1 ADCK1 SIN3A SIK3 AKAP9 MAP1S PDE4DIP EIF3B ARHGEF2 MAPK6 MAPK11 | 8.16e-13 | 910 | 203 | 28 | 36736316 |
| Pubmed | GPHN PDE1B HCN2 IQGAP1 NEFL DST AP1B1 AP2B1 GLUL IQSEC1 MIOS TACC3 HSPA8 ROCK2 DPYSL2 CNKSR2 LMNB2 JAKMIP3 HUWE1 SIK3 AKAP9 FARP1 EIF4A2 PDE4DIP DCHS1 ARHGEF2 LRRFIP2 | 1.81e-11 | 963 | 203 | 27 | 28671696 | |
| Pubmed | GPHN NEFL AP1B1 AP2B1 MIOS HSPA1A HSPA1B HSPA8 TARS1 CUL4B CUL2 CUL1 NIBAN2 TFRC RAI14 EIF3B ENO2 ENO3 ATP5F1A | 2.57e-11 | 451 | 203 | 19 | 36168627 | |
| Pubmed | GPHN ACADL IQGAP1 ITPR2 NEFL DST AP1B1 AP2B1 GLUL IQSEC1 MIOS MCAT HSPA1A HSPA1B HSPA2 SLC25A23 HSPA8 TARS1 ROCK2 DPYSL2 DPYSL3 ADGRL1 CNKSR2 MAP1S FARP1 PDE4DIP RAI14 ARHGEF2 ENO2 ATP5F1A DMTN LRRFIP2 | 7.21e-11 | 1431 | 203 | 32 | 37142655 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | GINS1 NEFL AP1B1 AP2B1 EXOC7 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 CUL4B ROCK2 CUL1 DPYSL2 DPYSL3 CDV3 DNAH2 POLR3A FAM50A EIF4A2 EIF3B ENO2 SNRPD3 ATP5F1A | 2.12e-10 | 847 | 203 | 24 | 35235311 |
| Pubmed | USP34 TTC6 IQGAP1 AP1B1 AP2B1 MCAT HSPA1A HSPA1L HSPA2 HSPA8 FKBP5 TARS1 CUL4B CUL2 CUL1 IFT74 LMNB2 HUWE1 POLR3A ORC2 NT5DC2 FLAD1 COPS4 PTRH2 EIF3B ARHGEF2 EIF2AK2 SNRPD3 SRSF9 ATP5F1A | 2.71e-10 | 1335 | 203 | 30 | 29229926 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACADL AKR1C1 AKR1C2 IQGAP1 DST AP1B1 AP2B1 HSPA1B HSPA1L HSPA2 HSPA8 TARS1 CUL1 RRAS2 NIBAN2 HUWE1 TFRC DNAH1 AKAP9 EIF3B PCCA CCDC9 ATP5F1A | 4.62e-10 | 807 | 203 | 23 | 30575818 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | IQGAP1 NEFL DST AP1B1 AP2B1 GLUL EXOC7 HSPA1A HSPA1L HSPA2 HSPA8 FKBP5 TARS1 DPYSL2 DPYSL3 CDV3 HUWE1 TFRC EIF4A2 NEMF COPS4 RAI14 EIF3B EIF2AK2 ENO2 SNRPD3 ATP5F1A | 8.91e-10 | 1149 | 203 | 27 | 35446349 |
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 1.13e-09 | 4 | 203 | 4 | 18299791 | |
| Pubmed | Variations in HSP70 genes associated with noise-induced hearing loss in two independent populations. | 1.13e-09 | 4 | 203 | 4 | 18813331 | |
| Pubmed | MYH4 IQGAP1 DST AP2B1 HSPA1A HSPA8 DPYSL2 RAI14 EIF3B ENO2 ATP5F1A LRRFIP2 | 1.57e-09 | 191 | 203 | 12 | 33762435 | |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 1.59e-09 | 10 | 203 | 5 | 22973535 | |
| Pubmed | NBPF12 ERCC6 FRMPD4 NEB STRIP2 DST NBPF14 HSPA1L HSPA2 NBPF8 CPNE9 NBPF11 NBPF15 NBPF9 NBPF10 TENM1 SNRPD3 ATP5F1A | 1.63e-09 | 513 | 203 | 18 | 25798074 | |
| Pubmed | GPHN PDE1B ITPR1 NEFL AP1B1 AP2B1 GLUL IQSEC1 HSPA2 HSPA8 ROCK2 DPYSL2 DPYSL3 ENO2 ATP5F1A DMTN | 2.38e-09 | 403 | 203 | 16 | 30562941 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 MAN2A1 IRAK1 RB1CC1 ADCY6 JAK1 ATP13A3 HSPA1A HSPA1L HSPA2 HSPA8 NOTCH2 SLC26A2 BICRA HUWE1 FAM50A PDE4DIP NEMF COPS4 PTRH2 TMF1 ATM ARHGEF2 PCCA CCDC9 | 3.75e-09 | 1061 | 203 | 25 | 33845483 |
| Pubmed | USP34 IRAK1 RB1CC1 NEK1 DST TACC3 HSPA1A HSPA1B VCPIP1 IFT74 BRMS1L HUWE1 TET1 TMF1 RAI14 PCCA | 3.99e-09 | 418 | 203 | 16 | 34709266 | |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | EXOC7 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 DPYSL2 HUWE1 TFRC EIF3B ATP5F1A | 4.37e-09 | 166 | 203 | 11 | 35687106 |
| Pubmed | 5.61e-09 | 5 | 203 | 4 | 17182002 | ||
| Pubmed | MYH4 NEB IQGAP1 DST AP2B1 GLUL HSPA1A HSPA1L HSPA2 HSPA8 TARS1 CUL4B DPYSL2 DPYSL3 CPNE9 HMCN1 NT5DC2 EIF4A2 EIF3B EIF2AK2 SNRPD3 ATP5F1A | 5.75e-09 | 844 | 203 | 22 | 25963833 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATRX ADCY6 IQGAP1 CACTIN IQSEC1 TACC3 HSPA8 FKBP5 NOTCH2 VCPIP1 CUL4B ROCK2 SIN3A NIBAN2 HUWE1 MAP1S EIF3B ATM ARHGEF2 SRSF9 CCDC9 | 6.53e-09 | 774 | 203 | 21 | 15302935 |
| Pubmed | USP34 ATRX AKR1C1 GINS1 AKR1C2 IQGAP1 CACTIN MED21 FKBP5 TARS1 CUL4B CUL2 CUL1 DPYSL2 LMNB2 SIN3A THOC5 POLR3A TFRC FAM50A EIF3B ATM EIF2AK2 SRSF9 | 7.23e-09 | 1014 | 203 | 24 | 32416067 | |
| Pubmed | UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. | 7.99e-09 | 13 | 203 | 5 | 27477512 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | RB1CC1 JAK1 HSPA1A HSPA1B HSPA2 HSPA8 LMNB2 SIN3A BRMS1L HUWE1 POLR3A ORC2 FARP1 RBPJ EIF3B ACAP2 SNRPD3 ATP5F1A | 1.18e-08 | 583 | 203 | 18 | 29844126 |
| Pubmed | ITPR2 DST HSPA1L HSPA8 TARS1 DNAH2 HMCN1 EIF4A2 ENO3 ATP5F1A | 1.25e-08 | 142 | 203 | 10 | 30809309 | |
| Pubmed | ATRX USE1 RB1CC1 ITPR1 ITPR2 CACTIN UTP15 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 FKBP5 TARS1 NOTCH2 CUL2 LMNB2 NIBAN2 SIK3 THOC5 TFRC WDR19 AKAP9 NT5DC2 FARP1 COPS4 PTRH2 ATM DNAJC3 | 1.32e-08 | 1487 | 203 | 29 | 33957083 | |
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 1.67e-08 | 6 | 203 | 4 | 7988674 | |
| Pubmed | USP34 USE1 IRAK1 IQGAP1 ITPR1 ITPR2 DST AP2B1 NFKB1 ATP13A3 EXOC7 HSPA2 FKBP5 CUL2 CUL1 VPS8 HUWE1 POLR3A TFRC CNNM4 PTRH2 EIF3B ATM ARHGEF2 SNRPD3 SRSF9 ATP5F1A LRRFIP2 | 2.58e-08 | 1440 | 203 | 28 | 30833792 | |
| Pubmed | MYH4 STAG1 ATRX CWC27 NEB ADCY6 IQGAP1 NEFL DST AP2B1 CCDC89 HSPA1L HSPA2 HSPA8 ROCK2 KRT12 DNAH2 LMNB2 TFRC FAM50A EIF4A2 TENM1 ZNF350 ATM ARHGEF2 MAPK6 DNAJC3 ATP5F1A | 2.66e-08 | 1442 | 203 | 28 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN ATRX IRAK1 NEK1 DST AP2B1 HSPA1A HSPA8 VCPIP1 DPYSL2 DPYSL3 CDV3 SIN3A NIBAN2 LZIC ORC2 FAM50A COPS4 RAI14 PCCA SNRPD3 ATP5F1A | 3.48e-08 | 934 | 203 | 22 | 33916271 |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | GPHN ADGRV1 IQGAP1 TACC3 HSPA1A HSPA8 CUL4B CUL2 CUL1 LMNB2 HUWE1 COPS4 EIF3B ACAP2 SNRPD3 ATP5F1A | 4.22e-08 | 495 | 203 | 16 | 28581483 |
| Pubmed | DEPDC1B coordinates de-adhesion events and cell-cycle progression at mitosis. | 5.18e-08 | 35 | 203 | 6 | 25458010 | |
| Pubmed | GPHN ERCC6 IQGAP1 PYGO2 TACC3 EXOC7 HSPA1A HSPA1B ROCK2 DPYSL2 NIBAN2 HUWE1 TMF1 ARHGEF2 SRSF9 EPHA1 | 5.26e-08 | 503 | 203 | 16 | 16964243 | |
| Pubmed | 6.95e-08 | 61 | 203 | 7 | 19875381 | ||
| Pubmed | TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A. | 7.34e-08 | 37 | 203 | 6 | 29531219 | |
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 7.74e-08 | 8 | 203 | 4 | 9122205 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | RB1CC1 IQGAP1 ITPR2 DST AP2B1 HSPA1L CDV3 JAKMIP3 POLR3A AKAP9 AGK ARHGEF2 SRSF9 | 8.28e-08 | 329 | 203 | 13 | 34316702 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | GPHN USP34 MAN2A1 ACADL ITGA1 IQGAP1 ITPR1 GLUL IQSEC1 HSPA8 NOTCH2 VCPIP1 DPYSL2 RRAS2 MAN2B2 SIN3A SIK3 TFRC AKAP9 NT5DC2 FARP1 EIF4A2 PTRH2 PCCA SNRPD3 DNAJC3 ATP5F1A | 1.14e-07 | 1451 | 203 | 27 | 30550785 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GPHN USP34 IQGAP1 AP1B1 AP2B1 GLUL UROD HSPA1A HSPA1L HSPA8 FKBP5 TARS1 VCPIP1 CUL4B ROCK2 CUL2 CUL1 DPYSL2 DPYSL3 CDV3 NIBAN2 HUWE1 MAP1S COPS4 EIF3B ENO2 SNRPD3 | 1.20e-07 | 1455 | 203 | 27 | 22863883 |
| Pubmed | CUL7: A DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex. | 1.22e-07 | 21 | 203 | 5 | 12481031 | |
| Pubmed | AMZ2 DST MIOS HSPA1B HSPA8 VCPIP1 KRT81 KRT83 KRT85 KRT86 TFRC ATP5F1A | 1.28e-07 | 284 | 203 | 12 | 29459677 | |
| Pubmed | ATRX RB1CC1 AMZ2 NEFL CACTIN NFKB1 CUL4B SIN3A BRMS1L HUWE1 KIF20A ORC2 EIF4A2 RBPJ CCDC9 | 1.30e-07 | 469 | 203 | 15 | 27634302 | |
| Pubmed | 1.39e-07 | 9 | 203 | 4 | 21763498 | ||
| Pubmed | 1.39e-07 | 9 | 203 | 4 | 8486356 | ||
| Pubmed | TTC9C NEK1 DST AP2B1 HSPA1A HSPA1B HSPA8 FKBP5 CUL1 SIN3A HUWE1 FAM50A NEMF COPS4 PTRH2 AGK | 1.64e-07 | 547 | 203 | 16 | 37267103 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 26496868 | ||
| Pubmed | Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies. | 1.96e-07 | 3 | 203 | 3 | 11779758 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 19439993 | ||
| Pubmed | Is preeclampsia associated with higher frequency of HSP70 gene polymorphisms? | 1.96e-07 | 3 | 203 | 3 | 16202503 | |
| Pubmed | Polymorphisms of heat shock protein 70 gene (HSPA1A, HSPA1B and HSPA1L) and schizophrenia. | 1.96e-07 | 3 | 203 | 3 | 15963589 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 15165109 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 23352621 | ||
| Pubmed | A prospective evaluation of the heat shock protein 70 gene polymorphisms and the risk of stroke. | 1.96e-07 | 3 | 203 | 3 | 12008944 | |
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 1.96e-07 | 3 | 203 | 3 | 25557232 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 23893339 | ||
| Pubmed | Chromosomal location of human genes encoding major heat-shock protein HSP70. | 1.96e-07 | 3 | 203 | 3 | 3470951 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 1.96e-07 | 3 | 203 | 3 | 1372089 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 2880793 | ||
| Pubmed | Analysis of the heat shock protein 70 (HSP70) genetic variants in nonsegmental vitiligo patients. | 1.96e-07 | 3 | 203 | 3 | 36345598 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 1712823 | ||
| Pubmed | Structure and expression of the three MHC-linked HSP70 genes. | 1.96e-07 | 3 | 203 | 3 | 1700760 | |
| Pubmed | Heat shock protein 70 gene polymorphism in Japanese patients with multiple sclerosis. | 1.96e-07 | 3 | 203 | 3 | 11696222 | |
| Pubmed | Sequences and differential expression of three novel human type-II hair keratins. | 1.96e-07 | 3 | 203 | 3 | 9084137 | |
| Pubmed | Analysis of heat-shock protein 70 gene polymorphisms and the risk of Parkinson's disease. | 1.96e-07 | 3 | 203 | 3 | 14605873 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 17582394 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 23666708 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 19085089 | ||
| Pubmed | Heat-shock protein-70 genes and response to antidepressants in major depression. | 1.96e-07 | 3 | 203 | 3 | 17428599 | |
| Pubmed | Heat shock protein 70 gene polymorphisms in sudden sensorineural hearing loss. | 1.96e-07 | 3 | 203 | 3 | 22922572 | |
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 1.96e-07 | 3 | 203 | 3 | 15129916 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 16333988 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 17009596 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 19840767 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 21373891 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 36246562 | ||
| Pubmed | Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes. | 1.96e-07 | 3 | 203 | 3 | 18518860 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 19351530 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 20012387 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 28025138 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 20704535 | ||
| Pubmed | Anti-inflammatory heat shock protein 70 genes are positively associated with human survival. | 1.96e-07 | 3 | 203 | 3 | 20388090 | |
| Pubmed | Human major histocompatibility complex contains genes for the major heat shock protein HSP70. | 1.96e-07 | 3 | 203 | 3 | 2538825 | |
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 9685725 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 20643136 | ||
| Pubmed | 1.96e-07 | 3 | 203 | 3 | 28182740 | ||
| Pubmed | The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. | 1.99e-07 | 23 | 203 | 5 | 21231916 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | FRMPD4 RB1CC1 IQGAP1 ITPR1 CACTIN DST AP2B1 UTP15 HSPA1A HSPA1B HSPA2 HSPA8 CUL1 FCF1 RAI14 EIF3B ARHGEF2 EIF2AK2 SNRPD3 ATP5F1A LRRFIP2 | 2.04e-07 | 949 | 203 | 21 | 36574265 |
| Pubmed | CWC27 IQGAP1 AP1B1 AP2B1 EXOC7 CUL4B CUL2 CUL1 DPYSL2 IFT74 SIN3A THOC5 MAP1S NT5DC2 AGK ATP5F1A | 2.25e-07 | 560 | 203 | 16 | 35241646 | |
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 2.30e-07 | 10 | 203 | 4 | 11932435 | |
| Pubmed | 2.30e-07 | 10 | 203 | 4 | 12832005 | ||
| Pubmed | 2.30e-07 | 10 | 203 | 4 | 7906708 | ||
| Pubmed | 2.30e-07 | 10 | 203 | 4 | 23921388 | ||
| Pubmed | IRAK1 IQGAP1 AP1B1 AP2B1 HSPA1B HSPA2 HSPA8 TARS1 CUL4B CUL1 LMNB2 SIN3A HUWE1 TFRC AGK EIF3B SRSF9 | 2.48e-07 | 638 | 203 | 17 | 33239621 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | USP34 EFCAB14 NEB STRIP2 DST HSPA8 FKBP5 CUL2 AKAP9 MAP1S PDE4DIP EIF3B EIF2AK2 ATP5F1A | 2.94e-07 | 432 | 203 | 14 | 23455922 |
| Pubmed | 3.01e-07 | 152 | 203 | 9 | 34299191 | ||
| Pubmed | IQGAP1 AP2B1 MED21 HSPA1A HSPA8 FKBP5 TARS1 ROCK2 CUL1 RRAS2 HUWE1 TEAD3 THOC5 DNAH1 AKAP9 NEMF RAI14 EIF3B ARHGEF2 EIF2AK2 SRSF9 CCDC9 ATP5F1A LRRFIP2 | 3.36e-07 | 1247 | 203 | 24 | 27684187 | |
| Pubmed | 3.95e-07 | 157 | 203 | 9 | 19423573 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | GPHN IQGAP1 AP1B1 AP2B1 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 VCPIP1 DPYSL2 HUWE1 TFRC COPS4 ENO2 SRSF9 ENO3 | 4.41e-07 | 665 | 203 | 17 | 30457570 |
| Interaction | STIP1 interactions | IRAK1 NEB GINS1 IQGAP1 AP1B1 AP2B1 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 FKBP5 TARS1 CUL4B CUL1 ADCK1 LMNB2 SIN3A HUWE1 SIK3 TFRC CCNF NRBP2 MAP1S FARP1 COPS4 AGK EIF3B MAPK6 ENO2 SRSF9 ENO3 | 6.54e-09 | 1006 | 202 | 32 | int:STIP1 |
| Interaction | FTCD interactions | 1.19e-08 | 29 | 202 | 7 | int:FTCD | |
| Interaction | PPP1R9B interactions | GPHN MYH4 PDE1B IQGAP1 ITPR1 NEFL AP1B1 AP2B1 GLUL IQSEC1 HSPA2 HSPA8 ROCK2 DPYSL2 DPYSL3 THOC5 TFRC KIF20A CCNF COPS4 ARHGEF2 ENO2 ATP5F1A DMTN | 1.96e-08 | 626 | 202 | 24 | int:PPP1R9B |
| Interaction | HDAC1 interactions | MYH4 ERCC6 STAG1 ATRX MIER3 IRAK1 RB1CC1 IQGAP1 NEK1 DST NFKB1 TACC3 HSPA1A HSPA1B HSPA8 VCPIP1 CUL4B IFT74 SIN3A BRMS1L THOC5 POLR3A KIF20A CCNF AKAP9 TET1 RBPJ TMF1 RAI14 ATM MAPK11 PCCA | 6.29e-08 | 1108 | 202 | 32 | int:HDAC1 |
| Interaction | VCP interactions | GPHN ERCC6 ATRX ITGA1 RB1CC1 NEB AKR1C1 GINS1 AKR1C2 IQGAP1 ITPR1 FCHSD2 AP1B1 AP2B1 NFKB1 GLUL UROD HSPA1A HSPA1B HSPA8 VCPIP1 CUL4B CUL2 CUL1 DPYSL2 IFT74 KRT81 LMNB2 NIBAN2 HUWE1 LZIC TFRC KIF20A CCNF EIF4A2 ARHGEF2 ATP5F1A | 9.37e-08 | 1435 | 202 | 37 | int:VCP |
| Interaction | FGD5 interactions | MYH4 IQGAP1 DST AP2B1 HSPA1A HSPA8 DPYSL2 AGK RAI14 EIF3B ENO2 ATP5F1A LRRFIP2 | 1.79e-07 | 207 | 202 | 13 | int:FGD5 |
| Interaction | HTT interactions | PDE1B ACADL ADCY6 ITPR1 NEFL DST AP1B1 AP2B1 GLUL MED21 HSPA1A HSPA2 HSPA8 ROCK2 CUL2 DPYSL2 DPYSL3 MAN2B2 LMNB2 SIN3A HUWE1 EIF3B ARHGEF2 EIF2AK2 SNRPD3 ENO3 CCDC9 ATP5F1A | 3.02e-07 | 949 | 202 | 28 | int:HTT |
| Interaction | ARHGAP24 interactions | GPHN NEFL AP1B1 AP2B1 MIOS HSPA1A HSPA1B HSPA8 TARS1 CUL4B CUL2 CUL1 NIBAN2 TFRC RAI14 EIF3B ENO2 ENO3 ATP5F1A | 4.81e-07 | 486 | 202 | 19 | int:ARHGAP24 |
| Interaction | SNW1 interactions | STAG1 ATRX CWC27 IQGAP1 AP1B1 EXOC7 HSPA1A HSPA1L HSPA2 HSPA8 CUL4B ROCK2 CUL2 CUL1 SIN3A NIBAN2 HUWE1 CCNF ORC2 RBPJ ATM ARHGEF2 MAPK6 SNRPD3 | 5.12e-07 | 747 | 202 | 24 | int:SNW1 |
| Interaction | EIF4A3 interactions | ERCC6 CWC27 RB1CC1 IQGAP1 JAK1 CACTIN HSPA1A HSPA8 CUL1 HUWE1 THOC5 TFRC KIF20A CCNF EIF4A2 EIF3B SNRPD3 SRSF9 CCDC9 | 7.15e-07 | 499 | 202 | 19 | int:EIF4A3 |
| Interaction | MCM2 interactions | MYH4 ATRX NEB IQGAP1 DST AP2B1 GLUL HSPA1A HSPA1L HSPA2 HSPA8 FKBP5 TARS1 CUL4B DPYSL2 DPYSL3 CPNE9 HUWE1 DNAH1 CCNF ORC2 HMCN1 NT5DC2 EIF4A2 EIF3B ATM EIF2AK2 SNRPD3 ATP5F1A | 1.27e-06 | 1081 | 202 | 29 | int:MCM2 |
| Interaction | PLD2 interactions | TTC9C HSPA1B HSPA2 HSPA8 FKBP5 VCPIP1 DPYSL2 CCNF EIF4A2 PCCA | 1.42e-06 | 139 | 202 | 10 | int:PLD2 |
| Interaction | METTL21A interactions | 1.43e-06 | 36 | 202 | 6 | int:METTL21A | |
| Interaction | LINC01554 interactions | ITPR2 DST HSPA1L HSPA8 TARS1 DNAH2 HMCN1 EIF4A2 ENO3 ATP5F1A | 1.73e-06 | 142 | 202 | 10 | int:LINC01554 |
| Interaction | NEK4 interactions | NBPF12 ERCC6 FRMPD4 NEB STRIP2 DST NBPF14 HSPA1L HSPA2 FKBP5 NBPF8 CUL4B CPNE9 NBPF11 NBPF15 NBPF9 NBPF10 TENM1 SNRPD3 ATP5F1A | 1.76e-06 | 582 | 202 | 20 | int:NEK4 |
| Interaction | EPS15 interactions | IQGAP1 AP1B1 AP2B1 HSPA1A HSPA1B HSPA1L HSPA8 DPYSL2 KRT83 KRT85 KRT86 CCNF | 2.38e-06 | 220 | 202 | 12 | int:EPS15 |
| Interaction | RCOR1 interactions | USP34 IRAK1 RB1CC1 NEK1 DST HSPA1A HSPA1B VCPIP1 CUL4B IFT74 SIN3A BRMS1L HUWE1 TET1 RBPJ TMF1 RAI14 PCCA | 2.64e-06 | 494 | 202 | 18 | int:RCOR1 |
| Interaction | RPL7P32 interactions | 3.06e-06 | 11 | 202 | 4 | int:RPL7P32 | |
| Interaction | HSP90AB1 interactions | IRAK1 RB1CC1 NEB TTC9C IQGAP1 FCHSD2 NFKB1 FGR HSPA1A HSPA1L HSPA2 HSPA8 FKBP5 CUL4B CUL2 CUL1 DPYSL2 ADCK1 DNAH2 HUWE1 SIK3 KIF20A CCNF COPS4 MAPK6 ATP5F1A | 4.02e-06 | 960 | 202 | 26 | int:HSP90AB1 |
| Interaction | EEF1AKMT3 interactions | USP34 ACTR5 IRAK1 NFKB1 IQSEC1 ABCD1 HSPA1L HSPA2 HSPA8 FKBP5 VCPIP1 NIBAN2 HUWE1 ARHGEF2 EIF2AK2 | 4.29e-06 | 364 | 202 | 15 | int:EEF1AKMT3 |
| Interaction | CCDC117 interactions | 5.34e-06 | 26 | 202 | 5 | int:CCDC117 | |
| Interaction | DPYSL2 interactions | RB1CC1 AP1B1 GLUL HSPA1A HSPA8 CUL4B ROCK2 CUL2 CACNA1F DPYSL2 DPYSL3 HUWE1 CCNF AGK | 5.84e-06 | 327 | 202 | 14 | int:DPYSL2 |
| Interaction | ARMC5 interactions | EXOC7 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 DPYSL2 HUWE1 TFRC EIF3B ATP5F1A | 6.11e-06 | 201 | 202 | 11 | int:ARMC5 |
| Interaction | PTOV1 interactions | 6.44e-06 | 70 | 202 | 7 | int:PTOV1 | |
| Interaction | HDAC2 interactions | CDR2 ERCC6 STAG1 MIER3 IQGAP1 AP2B1 NFKB1 HSPA8 TARS1 CUL4B DPYSL2 SIN3A BRMS1L HUWE1 POLR3A TFRC KIF20A CCNF TET1 RBPJ EIF3B ARHGEF2 EIF2AK2 SRSF9 | 6.51e-06 | 865 | 202 | 24 | int:HDAC2 |
| Interaction | MLF2 interactions | 7.04e-06 | 131 | 202 | 9 | int:MLF2 | |
| Interaction | KXD1 interactions | 8.65e-06 | 170 | 202 | 10 | int:KXD1 | |
| Interaction | SUGT1 interactions | IRAK1 TTC9C HSPA1A HSPA8 FKBP5 CUL1 DPYSL2 ADCK1 SIK3 CCNF NRBP2 MAPK6 LRRC23 | 8.66e-06 | 293 | 202 | 13 | int:SUGT1 |
| Interaction | KDM1A interactions | USP34 IRAK1 NBPF26 RB1CC1 NEFL NEK1 DST TACC3 EXOC7 HSPA1A HSPA1B VCPIP1 IFT74 SIN3A BRMS1L HUWE1 NBPF15 AKAP9 FAM50A TET1 PDE4DIP RBPJ TMF1 RAI14 PCCA | 8.71e-06 | 941 | 202 | 25 | int:KDM1A |
| Interaction | DSCAM interactions | 9.11e-06 | 171 | 202 | 10 | int:DSCAM | |
| Interaction | PHF21A interactions | USP34 IRAK1 RB1CC1 NEK1 DST TACC3 CUL4B IFT74 HUWE1 TET1 RBPJ TMF1 RAI14 PCCA | 1.01e-05 | 343 | 202 | 14 | int:PHF21A |
| Interaction | TULP3 interactions | NEB RGL1 DST SLBP IFT74 BRMS1L WDR19 AKAP9 NT5DC2 FLAD1 PDE4DIP COPS4 AGK ARHGEF2 | 1.11e-05 | 346 | 202 | 14 | int:TULP3 |
| Interaction | RECQL4 interactions | USP34 GINS1 TTC6 IQGAP1 AP1B1 AP2B1 MCAT HSPA1A HSPA1L HSPA2 HSPA8 FKBP5 TARS1 CUL4B CUL2 CUL1 CDV3 IFT74 LMNB2 HUWE1 POLR3A ORC2 NT5DC2 FLAD1 COPS4 PTRH2 EIF3B ARHGEF2 EIF2AK2 SNRPD3 SRSF9 ATP5F1A | 1.18e-05 | 1412 | 202 | 32 | int:RECQL4 |
| Interaction | CYP2W1 interactions | 1.23e-05 | 15 | 202 | 4 | int:CYP2W1 | |
| Interaction | DNAJC10 interactions | MAGEA11 RB1CC1 HSPA8 TARS1 CUL4B CUL2 CUL1 KIF20A CCNF AKAP9 PDE4DIP DNAJC3 | 1.31e-05 | 260 | 202 | 12 | int:DNAJC10 |
| Interaction | GPS1 interactions | IQGAP1 HSPA1A HSPA1L HSPA8 CUL4B CUL2 CUL1 HUWE1 CCNF COPS4 ATP5F1A | 1.32e-05 | 218 | 202 | 11 | int:GPS1 |
| Interaction | NCBP1 interactions | RB1CC1 NFKB1 SLBP HSPA1A HSPA8 CUL4B CUL1 HUWE1 THOC5 KIF20A CCNF FAM50A EIF3B SRSF9 | 1.39e-05 | 353 | 202 | 14 | int:NCBP1 |
| Interaction | C9orf78 interactions | CWC27 IQGAP1 FCHSD2 AP1B1 AP2B1 EXOC7 CUL4B CUL2 CUL1 DPYSL2 IFT74 SIN3A THOC5 MAP1S FAM50A NT5DC2 AGK MAPK11 ATP5F1A | 1.64e-05 | 620 | 202 | 19 | int:C9orf78 |
| Interaction | DENR interactions | 1.70e-05 | 81 | 202 | 7 | int:DENR | |
| Interaction | PINK1 interactions | IRAK1 RB1CC1 AKR1C2 IQGAP1 DST GLUL TACC3 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 FKBP5 IFT74 LMNB2 NIBAN2 HUWE1 RAI14 EIF3B ATP5F1A | 1.72e-05 | 679 | 202 | 20 | int:PINK1 |
| Interaction | CLTB interactions | GPHN IQGAP1 AP1B1 AP2B1 HSPA1B HSPA8 ROCK2 DPYSL2 HUWE1 CCNF | 1.81e-05 | 185 | 202 | 10 | int:CLTB |
| Interaction | BAP1 interactions | RB1CC1 IQGAP1 NEFL DST AP1B1 AP2B1 GLUL EXOC7 HSPA1A HSPA1L HSPA2 HSPA8 FKBP5 TARS1 CUL4B DPYSL2 RRAS2 DPYSL3 CDV3 HUWE1 TFRC EIF4A2 NEMF COPS4 RAI14 EIF3B EIF2AK2 ENO2 SNRPD3 ATP5F1A | 2.00e-05 | 1314 | 202 | 30 | int:BAP1 |
| Interaction | HGS interactions | CDR2 NEFL FCHSD2 STMN3 NFKB1 MED21 EXOC7 HSPA1A HSPA2 HSPA8 VPS37D IFT74 KRT86 TFRC CCNF GUCA1C PTRH2 | 2.22e-05 | 523 | 202 | 17 | int:HGS |
| Interaction | KCTD13 interactions | GPHN ACADL IQGAP1 ITPR2 NEFL DST AP1B1 AP2B1 GLUL IQSEC1 MIOS MCAT HSPA1A HSPA1L HSPA2 SLC25A23 HSPA8 TARS1 ROCK2 DPYSL2 DPYSL3 ADGRL1 CNKSR2 MAP1S FARP1 RAI14 ARHGEF2 ENO2 ATP5F1A DMTN LRRFIP2 | 2.38e-05 | 1394 | 202 | 31 | int:KCTD13 |
| Interaction | PTP4A3 interactions | 2.58e-05 | 154 | 202 | 9 | int:PTP4A3 | |
| Interaction | FAM83F interactions | 2.82e-05 | 36 | 202 | 5 | int:FAM83F | |
| Interaction | KCNMA1 interactions | NEFL HSPA1L HSPA2 HSPA8 CUL1 DPYSL2 EIF4A2 ENO2 ENO3 ATP5F1A | 2.97e-05 | 196 | 202 | 10 | int:KCNMA1 |
| Interaction | DNAJB6 interactions | UTP15 IQSEC1 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 FKBP5 CUL2 LMNB2 HUWE1 NRBP2 MAPK6 DNAJC3 | 3.04e-05 | 379 | 202 | 14 | int:DNAJB6 |
| Interaction | TNIK interactions | DST AP2B1 GLUL IQSEC1 HSPA1A DPYSL2 DPYSL3 CNKSR2 LMNB2 HUWE1 AKAP9 PDE4DIP DCHS1 ARHGEF2 | 3.22e-05 | 381 | 202 | 14 | int:TNIK |
| Interaction | GLUL interactions | 3.49e-05 | 160 | 202 | 9 | int:GLUL | |
| Interaction | HSPA1L interactions | NFKB1 HSPA1A HSPA1L HSPA2 SLC25A23 HSPA8 FKBP5 CUL4B CUL2 CUL1 DNAJC3 ATP5F1A | 3.70e-05 | 289 | 202 | 12 | int:HSPA1L |
| Interaction | COPS3 interactions | ERCC6 HSPA1L HSPA8 CUL4B CUL2 CUL1 HUWE1 CCNF FLAD1 COPS4 ATP5F1A | 3.87e-05 | 245 | 202 | 11 | int:COPS3 |
| Interaction | RHOB interactions | ITGA1 ADCY6 IQGAP1 JAK1 AP2B1 IQSEC1 ATP13A3 NOTCH2 ROCK2 CUL2 RRAS2 SLC26A2 ADGRL1 NIBAN2 RALGAPA2 TFRC KIF20A CNNM4 FARP1 PTRH2 RAI14 ARHGEF2 | 3.89e-05 | 840 | 202 | 22 | int:RHOB |
| Interaction | KLHL34 interactions | 3.98e-05 | 63 | 202 | 6 | int:KLHL34 | |
| Interaction | ISG15 interactions | AKR1C2 IQGAP1 JAK1 AP2B1 HSPA1A HSPA1B HSPA8 TARS1 KRT81 SIN3A SIK3 TFRC RAI14 EIF2AK2 ATP5F1A LRRFIP2 | 4.07e-05 | 494 | 202 | 16 | int:ISG15 |
| Interaction | MXD3 interactions | 4.76e-05 | 40 | 202 | 5 | int:MXD3 | |
| Interaction | HUWE1 interactions | GPHN USP34 MAGEA11 RB1CC1 IQGAP1 GLUL HSPA1A HSPA1B HSPA8 TARS1 VCPIP1 CUL4B CUL1 DPYSL2 HUWE1 TFRC CCNF AKAP9 COPS4 EIF3B ATM MAPK6 PCCA SNRPD3 ATP5F1A EPHA1 | 4.95e-05 | 1110 | 202 | 26 | int:HUWE1 |
| Interaction | CUL4A interactions | USP34 ERCC6 MAN2A1 PYGO2 NFKB1 SLBP HSPA1A HSPA1B HSPA1L HSPA8 CUL4B CUL2 CUL1 DPYSL2 KRT85 LMNB2 TET1 COPS4 RAI14 ENO2 SNRPD3 MYBPC3 | 4.97e-05 | 854 | 202 | 22 | int:CUL4A |
| Interaction | CDC5L interactions | CWC27 IQGAP1 CACTIN DST AP1B1 EXOC7 HSPA1L HSPA2 HSPA8 ROCK2 CUL1 NIBAN2 HUWE1 CCNF ORC2 AKAP9 EIF4A2 PDE4DIP ARHGEF2 EIF2AK2 SNRPD3 SRSF9 | 5.05e-05 | 855 | 202 | 22 | int:CDC5L |
| Interaction | ADAMTS17 interactions | 5.13e-05 | 21 | 202 | 4 | int:ADAMTS17 | |
| Interaction | CAPZB interactions | IQGAP1 ITPR1 ITPR2 AP2B1 NFKB1 HSPA1A HSPA1B HSPA8 FKBP5 CUL4B CUL2 HUWE1 TFRC KIF20A CCNF FAM50A NT5DC2 EIF4A2 RAI14 EIF3B ARHGEF2 ACAP2 SNRPD3 ATP5F1A LRRFIP2 | 5.30e-05 | 1049 | 202 | 25 | int:CAPZB |
| Interaction | AGAP2 interactions | 5.34e-05 | 210 | 202 | 10 | int:AGAP2 | |
| Interaction | RPL21P19 interactions | 5.35e-05 | 8 | 202 | 3 | int:RPL21P19 | |
| Interaction | RPL21P16 interactions | 5.35e-05 | 8 | 202 | 3 | int:RPL21P16 | |
| Interaction | PELI3 interactions | 5.38e-05 | 41 | 202 | 5 | int:PELI3 | |
| Interaction | YWHAZ interactions | CDR2 PDE6C PDE1B CWC27 RB1CC1 NEB ITPR1 NEFL NEK1 DST AP2B1 HSPA1A HSPA1B HSPA2 HSPA8 CUL2 CUL1 DPYSL2 RRAS2 CNKSR2 HUWE1 SIK3 CCNF AKAP9 RAI14 ATM ARHGEF2 ATP5F1A DMTN | 5.51e-05 | 1319 | 202 | 29 | int:YWHAZ |
| Interaction | PNKD interactions | 5.65e-05 | 132 | 202 | 8 | int:PNKD | |
| Interaction | RBP1 interactions | 6.06e-05 | 42 | 202 | 5 | int:RBP1 | |
| Interaction | SNX20 interactions | 6.22e-05 | 22 | 202 | 4 | int:SNX20 | |
| Interaction | HDAC4 interactions | CDR2 STAG1 ATRX IQGAP1 ITPR1 FCHSD2 NFKB1 MIOS HSPA1A HSPA8 ZMYND12 SIN3A HUWE1 MAP1S NEMF EIF3B ATM DNAJC3 ATP5F1A LRRFIP2 | 6.22e-05 | 744 | 202 | 20 | int:HDAC4 |
| Interaction | EDRF1 interactions | 6.26e-05 | 99 | 202 | 7 | int:EDRF1 | |
| Interaction | MCM4 interactions | ATRX IRAK1 HSPA8 FKBP5 HUWE1 KIF20A CCNF ORC2 NEMF EIF3B MAPK6 MAPK11 | 6.42e-05 | 306 | 202 | 12 | int:MCM4 |
| Interaction | AGR2 interactions | ACADL AKR1C1 AKR1C2 IQGAP1 DST AP1B1 AP2B1 HSPA1B HSPA1L HSPA2 HSPA8 TARS1 CUL1 RRAS2 NIBAN2 HUWE1 TFRC DNAH1 AKAP9 EIF3B PCCA CCDC9 ATP5F1A | 6.60e-05 | 934 | 202 | 23 | int:AGR2 |
| Interaction | COPS6 interactions | ERCC6 NFKB1 HSPA1A HSPA1B HSPA1L HSPA8 CUL4B CUL2 CUL1 SIN3A HUWE1 COPS4 MAPK6 ATP5F1A | 6.75e-05 | 408 | 202 | 14 | int:COPS6 |
| Interaction | AIMP1 interactions | IQGAP1 GLUL HSPA1A HSPA8 TARS1 CUL2 CUL1 DPYSL2 EIF4A2 SNRPD3 ATP5F1A | 7.34e-05 | 263 | 202 | 11 | int:AIMP1 |
| Interaction | NLRC5 interactions | 7.47e-05 | 23 | 202 | 4 | int:NLRC5 | |
| Interaction | HNRNPA2B1 interactions | ERCC6 CWC27 AP1B1 AP2B1 FGR HSPA1A HSPA1B HSPA1L HSPA8 CUL4B CUL2 CUL1 DNAH2 HUWE1 KIF20A CCNF MAP1S SNRPD3 SRSF9 DNAJC3 | 7.47e-05 | 754 | 202 | 20 | int:HNRNPA2B1 |
| Interaction | DNAJB2 interactions | 7.57e-05 | 102 | 202 | 7 | int:DNAJB2 | |
| Interaction | AMBRA1 interactions | IRAK1 HSPA1A HSPA8 CUL4B CUL1 HUWE1 KIF20A CCNF NRBP2 COPS4 MAPK6 | 7.85e-05 | 265 | 202 | 11 | int:AMBRA1 |
| Interaction | DDB1 interactions | ERCC6 ACTR5 IRAK1 IQGAP1 PYGO2 SLBP HSPA8 CUL4B CUL1 SIN3A HUWE1 KIF20A WDR19 CCNF NRBP2 FARP1 TET1 COPS4 SRSF9 | 7.97e-05 | 697 | 202 | 19 | int:DDB1 |
| Interaction | RPL29P30 interactions | 7.97e-05 | 9 | 202 | 3 | int:RPL29P30 | |
| Interaction | CCNI2 interactions | 7.97e-05 | 9 | 202 | 3 | int:CCNI2 | |
| Interaction | HEY1 interactions | 8.56e-05 | 140 | 202 | 8 | int:HEY1 | |
| Interaction | UBE2M interactions | GPHN ADGRV1 IQGAP1 TACC3 HSPA1A HSPA1L HSPA8 CUL4B CUL2 CUL1 LMNB2 HUWE1 CCNF COPS4 EIF3B ACAP2 SNRPD3 ATP5F1A | 1.03e-04 | 651 | 202 | 18 | int:UBE2M |
| Interaction | DNAJC7 interactions | IRAK1 IQSEC1 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 TARS1 HUWE1 WDR19 CCNF ATM MAPK6 DNAJC3 | 1.04e-04 | 425 | 202 | 14 | int:DNAJC7 |
| Interaction | PPP1R12A interactions | RB1CC1 IQGAP1 HSPA1A HSPA2 HSPA8 ROCK2 CUL1 CDV3 KIF20A CCNF COPS4 RAI14 | 1.04e-04 | 322 | 202 | 12 | int:PPP1R12A |
| Interaction | TRIM38 interactions | 1.05e-04 | 47 | 202 | 5 | int:TRIM38 | |
| Interaction | TTC7A interactions | 1.05e-04 | 25 | 202 | 4 | int:TTC7A | |
| Interaction | SPRTN interactions | IRAK1 TTC9C NAA25 HSPA1A HSPA1B HSPA1L HSPA2 HSPA8 VCPIP1 ROCK2 HUWE1 RALGAPA2 TFRC EIF4A2 AGK ENO3 ATP5F1A | 1.12e-04 | 596 | 202 | 17 | int:SPRTN |
| Interaction | CCDC142 interactions | 1.13e-04 | 10 | 202 | 3 | int:CCDC142 | |
| Interaction | IGHV3OR15-7 interactions | 1.13e-04 | 10 | 202 | 3 | int:IGHV3OR15-7 | |
| Interaction | RPL7AP9 interactions | 1.13e-04 | 10 | 202 | 3 | int:RPL7AP9 | |
| Interaction | SOCS3 interactions | 1.22e-04 | 110 | 202 | 7 | int:SOCS3 | |
| Interaction | CDC34 interactions | HSPA1A HSPA1B HSPA2 HSPA8 TARS1 CUL2 CUL1 HUWE1 CCNF PTRH2 EIF3B CCDC9 | 1.24e-04 | 328 | 202 | 12 | int:CDC34 |
| Interaction | DNAJC16 interactions | 1.26e-04 | 233 | 202 | 10 | int:DNAJC16 | |
| Interaction | MAP3K7 interactions | IRAK1 HSPA1A HSPA1L HSPA2 FKBP5 TARS1 CUL4B CUL1 SIK3 CCNF ATM MAPK6 EIF2AK2 | 1.27e-04 | 380 | 202 | 13 | int:MAP3K7 |
| Interaction | KTN1 interactions | CDR2 RB1CC1 DST HSPA1A HSPA8 FKBP5 TFRC KIF20A CCNF EIF3B SNRPD3 DNAJC3 | 1.35e-04 | 331 | 202 | 12 | int:KTN1 |
| Interaction | ATG3 interactions | RB1CC1 UTP15 UROD HSPA1A KRT85 HUWE1 POLR3A CCNF FCF1 MAP1S RBPJ | 1.36e-04 | 282 | 202 | 11 | int:ATG3 |
| Interaction | NSFL1C interactions | 1.42e-04 | 192 | 202 | 9 | int:NSFL1C | |
| Interaction | SYNPO interactions | 1.42e-04 | 192 | 202 | 9 | int:SYNPO | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | NBPF12 NBPF19 PYGO2 NBPF14 NBPF11 NBPF20 NBPF15 NBPF9 FLAD1 PDE4DIP NBPF10 | 2.17e-06 | 404 | 203 | 11 | chr1q21 |
| Cytoband | 1q21.1 | 8.48e-06 | 62 | 203 | 5 | 1q21.1 | |
| Cytoband | 12q13 | 1.65e-05 | 71 | 203 | 5 | 12q13 | |
| Cytoband | 10p15-p14 | 2.88e-04 | 6 | 203 | 2 | 10p15-p14 | |
| GeneFamily | Neuroblastoma breakpoint family | NBPF12 NBPF26 NBPF19 NBPF14 NBPF8 NBPF11 NBPF20 NBPF15 NBPF9 NBPF10 | 5.46e-16 | 23 | 139 | 10 | 662 |
| GeneFamily | Heat shock 70kDa proteins | 1.44e-07 | 17 | 139 | 5 | 583 | |
| GeneFamily | Cullins | 2.42e-05 | 8 | 139 | 3 | 1032 | |
| GeneFamily | Keratins, type II | 5.12e-05 | 27 | 139 | 4 | 609 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.75e-04 | 3 | 139 | 2 | 297 | |
| GeneFamily | Dyneins, axonemal | 2.79e-04 | 17 | 139 | 3 | 536 | |
| GeneFamily | Mannosidases alpha class 2 | 5.78e-04 | 5 | 139 | 2 | 1194 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.77e-03 | 181 | 139 | 6 | 694 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 MAN2A1 STAG1 ATRX RB1CC1 GINS1 ITPR1 RGL1 NEK1 FCHSD2 DST NFKB1 ATP13A3 NBPF14 ROCK2 CUL2 CUL1 RRAS2 SIK3 ORC2 AKAP9 RBPJ MAPK6 PCCA ACAP2 PLCE1 | 2.47e-09 | 856 | 201 | 26 | M4500 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | MYH4 NBPF12 MIER3 ADGRV1 GIMAP7 NME8 FCHSD2 FKBP5 VPS37D NBPF8 DPYSL3 KRT81 KRT83 KRT86 VPS8 RAB44 POLR3A TET1 NBPF10 TENM1 DNAJC3 | 4.01e-06 | 873 | 201 | 21 | M16009 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 4.18e-06 | 85 | 201 | 7 | M10575 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 9.66e-06 | 177 | 201 | 9 | M9401 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP34 ATRX ITGA1 GIMAP7 RB1CC1 IQGAP1 ITPR1 ITPR2 JAK1 STMN3 HSPA8 FKBP5 NOTCH2 RALGDS CDV3 SLC26A2 SIN3A HUWE1 SIK3 ARHGAP4 AKAP9 EIF4A2 PDE4DIP NEMF RBPJ TMF1 ATM ACAP2 | 1.10e-05 | 1492 | 201 | 28 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MAN2A1 STAG1 ATRX GINS1 FCHSD2 DST ATP13A3 ROCK2 CUL1 RRAS2 ORC2 AKAP9 RBPJ MAPK6 | 1.60e-05 | 466 | 201 | 14 | M13522 |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 1.69e-05 | 105 | 201 | 7 | M12602 | |
| Coexpression | IBRAHIM_NRF2_UP | MIER3 RB1CC1 AKR1C1 AKR1C2 UTP15 HSPA8 TARS1 CUL2 CUL1 RRAS2 TFRC MAPK6 ACAP2 DNAJC3 LRRFIP2 | 1.71e-05 | 533 | 201 | 15 | M42510 |
| Coexpression | GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN | 2.49e-05 | 153 | 201 | 8 | M350 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP | 2.56e-05 | 200 | 201 | 9 | M9652 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | GPHN USP34 MIER3 AKR1C1 IQGAP1 JAK1 NEFL DST ATP13A3 NBPF14 CUL4B DPYSL3 CDV3 TFRC | 3.11e-05 | 495 | 201 | 14 | M8451 |
| Coexpression | TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL | APOBEC3A IQGAP1 RGL1 AP1B1 NFKB1 GLUL IQSEC1 ATP13A3 FGR FKBP5 DPYSL2 CDV3 NIBAN2 TFRC RBPJ | 4.26e-05 | 577 | 201 | 15 | M41697 |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 4.40e-05 | 26 | 201 | 4 | M1380 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | USP34 STAG1 ATRX IRAK1 IQGAP1 UTP15 MIOS ATP13A3 NBPF14 TARS1 CUL4B RRAS2 LZIC TFRC EIF4A2 NEMF ACAP2 | 4.45e-05 | 721 | 201 | 17 | M10237 |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 5.12e-05 | 10 | 201 | 3 | MM1243 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 7.01e-05 | 177 | 201 | 8 | M39245 | |
| Coexpression | TBK1.DF_DN | CDR2 ADCY6 NEK1 ROCK2 SLC26A2 AKAP9 COPS4 RAI14 ACAP2 DNAJC3 | 7.76e-05 | 286 | 201 | 10 | M2864 |
| Coexpression | CAFFAREL_RESPONSE_TO_THC_8HR_5_DN | 9.29e-05 | 12 | 201 | 3 | M2260 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP | 9.32e-05 | 137 | 201 | 7 | M34024 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | ATRX USE1 RB1CC1 ITPR1 NEFL AP2B1 STMN3 GLUL HSPA8 ROCK2 CUL2 CUL1 CNKSR2 THOC5 TFRC PDE4DIP TENM1 COPS4 PTRH2 PCCA ENO2 ATP5F1A DMTN | 9.38e-05 | 1248 | 201 | 23 | M17728 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | MAN2A1 CWC27 RB1CC1 TTC9C AP2B1 IQSEC1 ATP13A3 ROCK2 DPYSL2 HUWE1 RALGAPA2 LZIC KIF20A NT5DC2 TET1 RAI14 MAPK6 PLCE1 | 9.69e-05 | 845 | 201 | 18 | M18090 |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 9.91e-05 | 186 | 201 | 8 | M8175 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | JAK1 STMN3 IQSEC1 NBPF14 RALGDS BICRA POLG NIBAN2 SIK3 NBPF11 DNAH1 ARHGAP4 NRBP2 NBPF10 ENO3 | 1.21e-04 | 634 | 201 | 15 | M40866 |
| Coexpression | GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP | 1.28e-04 | 193 | 201 | 8 | M3303 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.42e-04 | 250 | 201 | 9 | M11318 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 1.47e-04 | 197 | 201 | 8 | M8271 | |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 1.54e-04 | 66 | 201 | 5 | MM631 | |
| Coexpression | TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL | IRAK1 APOBEC3A IQGAP1 JAK1 RGL1 NFKB1 ATP13A3 FGR NBPF14 FKBP5 NOTCH2 RALGDS CDV3 NIBAN2 TFRC NBPF10 | 1.58e-04 | 724 | 201 | 16 | M41700 |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP | 1.58e-04 | 199 | 201 | 8 | M8961 | |
| Coexpression | GSE3982_MAST_CELL_VS_NKCELL_UP | 1.58e-04 | 199 | 201 | 8 | M5450 | |
| Coexpression | GSE19512_NAUTRAL_VS_INDUCED_TREG_DN | 1.63e-04 | 200 | 201 | 8 | M8359 | |
| Coexpression | GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 1.63e-04 | 200 | 201 | 8 | M9554 | |
| Coexpression | GSE2826_XID_VS_BTK_KO_BCELL_UP | 1.63e-04 | 200 | 201 | 8 | M4900 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TCONV_DN | 1.63e-04 | 200 | 201 | 8 | M5746 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | MYCL EFCAB14 JAK1 FCHSD2 IQSEC1 SLBP FGR TACC3 UROD HSPA8 ZMYND12 JAKMIP3 SIK3 LZIC POLR3A RBPJ ATM | 1.73e-04 | 807 | 201 | 17 | M14594 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CWC27 RB1CC1 ITPR1 ITPR2 NEK1 CUL4B CUL2 IFT74 NEMF TMF1 RAI14 ATM MAPK6 PCCA DNAJC3 | 1.76e-04 | 656 | 201 | 15 | M18979 |
| Coexpression | ENGELMANN_CANCER_PROGENITORS_DN | 1.90e-04 | 69 | 201 | 5 | M9246 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 2.01e-04 | 155 | 201 | 7 | M39246 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | ITGA1 GINS1 NAA25 MED21 SLBP FKBP5 TARS1 CUL1 DPYSL2 LMNB2 TFRC KIF20A CCNF ORC2 FBH1 NBPF9 FLAD1 TET1 RBPJ PTRH2 AGK RAI14 EIF3B EIF2AK2 | 2.11e-04 | 1407 | 201 | 24 | M14427 |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP | 2.20e-04 | 265 | 201 | 9 | M2255 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.45e-06 | 146 | 195 | 9 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#2 | MAN2A1 MIER3 ITPR1 NEFL CACTIN NAA25 UTP15 ATP13A3 TARS1 CUL2 RRAS2 BICRA LMNB2 POLR3A KIF20A CCNF ORC2 HMCN1 NT5DC2 EIF3B ARHGEF2 DNAJC3 ENO3 | 1.66e-05 | 933 | 195 | 23 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K2 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 ADGRV1 NEB DNAH5 CACNA1F CNKSR2 DNAH1 LOXHD1 HMCN1 TENM1 PLCE1 | 8.74e-10 | 184 | 202 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 ADGRV1 NEB DNAH5 CACNA1F CNKSR2 DNAH1 LOXHD1 HMCN1 TENM1 PLCE1 | 8.74e-10 | 184 | 202 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRMPD4 ADGRV1 NEB DNAH5 CACNA1F CNKSR2 DNAH1 LOXHD1 HMCN1 TENM1 PLCE1 | 8.74e-10 | 184 | 202 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-07 | 176 | 202 | 9 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-06 | 173 | 202 | 8 | 5d3c917e4d0de3158550a8ab2006ddfa87159ffa | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 1.81e-06 | 181 | 202 | 8 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.40e-06 | 188 | 202 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 2.49e-06 | 189 | 202 | 8 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.49e-06 | 189 | 202 | 8 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.49e-06 | 189 | 202 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-06 | 189 | 202 | 8 | 5c85656f555d91ecc9540faa67717694a4aef92f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.70e-06 | 191 | 202 | 8 | c4a2a8a7b864df282546e6ac53fcb2269cbb3345 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-06 | 192 | 202 | 8 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.91e-06 | 193 | 202 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 2.91e-06 | 193 | 202 | 8 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.91e-06 | 193 | 202 | 8 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.91e-06 | 193 | 202 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 194 | 202 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 195 | 202 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.27e-06 | 196 | 202 | 8 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-06 | 197 | 202 | 8 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.65e-06 | 199 | 202 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.65e-06 | 199 | 202 | 8 | 5de2a32bc2e9c752eb19a013b1807949153728fc | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.03e-06 | 155 | 202 | 7 | c4dc0fa1d0e657753a56939eb4829fb60382c17f | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor | 1.10e-05 | 166 | 202 | 7 | be284e2e596390f05305c7bcfc316f87b963fc0b | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 169 | 202 | 7 | d4a0bd792bddfa34332d7dc432ce253f50d98c6f | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.28e-05 | 170 | 202 | 7 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-05 | 170 | 202 | 7 | 65c7ed586e7615203a59999549892ed466a89502 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.55e-05 | 175 | 202 | 7 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 175 | 202 | 7 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 180 | 202 | 7 | 729f0d7af573c7796d8e28e6eec3af2fc0bd33a2 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 180 | 202 | 7 | 9ef79a7c60227e352ac166c7274adb31f585f5ca | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.92e-05 | 181 | 202 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 1.99e-05 | 182 | 202 | 7 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-05 | 182 | 202 | 7 | e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.99e-05 | 182 | 202 | 7 | 111d434b89902ec11fb07f41b8ee1a98f3991b61 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 184 | 202 | 7 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 2.14e-05 | 184 | 202 | 7 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | COVID-CD4-CD8_1|COVID / Condition, Cell_class and T cell subcluster | 2.22e-05 | 185 | 202 | 7 | c634bb04a081ae3214b68f6e4a147db5b2b916ed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-05 | 187 | 202 | 7 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.37e-05 | 187 | 202 | 7 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-05 | 187 | 202 | 7 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 187 | 202 | 7 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.37e-05 | 187 | 202 | 7 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 187 | 202 | 7 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.37e-05 | 187 | 202 | 7 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 187 | 202 | 7 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.37e-05 | 187 | 202 | 7 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 2.63e-05 | 190 | 202 | 7 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 190 | 202 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 191 | 202 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 2.72e-05 | 191 | 202 | 7 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 191 | 202 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 192 | 202 | 7 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.90e-05 | 193 | 202 | 7 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | Mild_COVID-19-T/NK-NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.90e-05 | 193 | 202 | 7 | 9c455d9d845fa230e9a61d9a5f9d6a2ccf5d7350 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 194 | 202 | 7 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 202 | 7 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 194 | 202 | 7 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 194 | 202 | 7 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.10e-05 | 195 | 202 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Control-Lymphocyte-T_NK-NK_CD56bright|Control / Disease, Lineage and Cell Type | 3.20e-05 | 196 | 202 | 7 | c0ebef067aa333c7a18c697031b0417b3335b75c | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 197 | 202 | 7 | d6eb843f5ee1b1ea54416ba6e987eefe86ca3216 | |
| ToppCell | Severe-NK|World / Disease group and Cell class | 3.31e-05 | 197 | 202 | 7 | 1e5fb79385657a467c2d9f942d8cafb8ef7826c9 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intermediate_macrophages|Lung / Manually curated celltypes from each tissue | 3.31e-05 | 197 | 202 | 7 | bcb4dc17dae705bd84ea6a2842d6b107562baeb7 | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.42e-05 | 198 | 202 | 7 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | 367C|World / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-05 | 198 | 202 | 7 | ab3a178f392204e2d90eb5a3b5de7849986b1eaf | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.42e-05 | 198 | 202 | 7 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | Transverse-T_cell-Th1|T_cell / Region, Cell class and subclass | 3.53e-05 | 199 | 202 | 7 | 9271d9d36ffe1c169049d4340258f366916adfaf | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 3.53e-05 | 199 | 202 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 202 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 3.53e-05 | 199 | 202 | 7 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 3.53e-05 | 199 | 202 | 7 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD14|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 200 | 202 | 7 | 54221271becd02a4ffa826e06c8e76fcd2651d50 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 3.64e-05 | 200 | 202 | 7 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.64e-05 | 200 | 202 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.64e-05 | 200 | 202 | 7 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.64e-05 | 200 | 202 | 7 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-NK_CD56bright|URO / Disease, condition lineage and cell class | 3.64e-05 | 200 | 202 | 7 | 2fff822145ec298445595ba64334e6a1db8254f4 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.99e-05 | 138 | 202 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | PBMC-Severe-cDC_8|Severe / Compartment, Disease Groups and Clusters | 5.27e-05 | 145 | 202 | 6 | 23a9a4fd1934c4a38d9259105c1fdbac459575cb | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-05 | 150 | 202 | 6 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | (04)_Pre-ciliated-(2)_48hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 8.77e-05 | 159 | 202 | 6 | e1f36b237e314ef6a18224eb8f3b97a612c39506 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.77e-05 | 159 | 202 | 6 | ba82d1f55dd77c4b2183981b76cab1480fba75ad | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.08e-05 | 160 | 202 | 6 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.70e-05 | 101 | 202 | 5 | 657d3994b93e2fbb1ff96f701ff2ea6665e5a15c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.72e-05 | 162 | 202 | 6 | 9b1c07f0af657095379380c39d763cab0ad73e74 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 165 | 202 | 6 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 165 | 202 | 6 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 169 | 202 | 6 | d59c8cd0719ed0947d42da9e7e5da72ff58ecc0d | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 171 | 202 | 6 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 171 | 202 | 6 | 285533ca2a6a411773313166bee35542f34d1a3c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 171 | 202 | 6 | f16cb64b8844c2668922c786888efaa9f873afcc | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 171 | 202 | 6 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 171 | 202 | 6 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 171 | 202 | 6 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Deptor_(Deep_layer_pyramidal_cells--Layer_5a)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 108 | 202 | 5 | 514dfc3f7ac303311ae599f981f3f3c7eb6801b8 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.35e-04 | 172 | 202 | 6 | 48d0cfc37d1b1ae48ed8f8b2711abeb609d2bb6e | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 173 | 202 | 6 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 173 | 202 | 6 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | CACTIN AP1B1 GLUL ABCD1 HSPA2 FKBP5 VCPIP1 ROCK2 CUL2 ADGRL1 LMNB2 FCF1 ENO2 LRRC23 | 2.73e-09 | 198 | 201 | 14 | 3446_DN |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | ACTR5 CACTIN NEK1 ATP13A3 FKBP5 NOTCH2 ROCK2 RALGDS ZNF350 ATM MAPK11 LRRC23 | 2.08e-07 | 198 | 201 | 12 | 5334_UP |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | ACTR5 PGPEP1 ITPR1 RGL1 EXOC7 SLC26A2 KRT83 AKAP9 FARP1 MAPK11 DMTN | 1.37e-06 | 195 | 201 | 11 | 5474_UP |
| Drug | phorbol acetate myristate | MYCL ITGA1 ADCY6 APOBEC3A IQGAP1 ITPR1 JAK1 DST NFKB1 MED21 FGR HSPA2 HSPA8 ROCK2 CACNA1F KRT12 KRT81 KRT83 KRT85 KRT86 POLG LMNB2 TFRC WDR19 EIF4A2 AGK ARHGEF2 MAPK6 MAPK11 EIF2AK2 PLCE1 | 2.04e-06 | 1399 | 201 | 31 | CID000004792 |
| Drug | trioxane | 3.96e-06 | 13 | 201 | 4 | CID000008081 | |
| Drug | B-43 | 5.51e-06 | 14 | 201 | 4 | CID006603792 | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 7.35e-06 | 189 | 201 | 10 | 2041_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 7.70e-06 | 190 | 201 | 10 | 3172_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A | ACTR5 USE1 PGPEP1 NEB EXOC7 SLC25A23 VCPIP1 ATM ARHGEF2 EPHA1 | 8.84e-06 | 193 | 201 | 10 | 5986_DN |
| Drug | Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | NEK1 EXOC7 SLC25A23 NOTCH2 ROCK2 KRT83 POLG THOC5 PDE4DIP MAPK11 | 9.25e-06 | 194 | 201 | 10 | 3193_DN |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.06e-05 | 197 | 201 | 10 | 3176_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | USP34 ITPR1 EXOC7 VCPIP1 POLG ADGRL1 PDE4DIP ARHGEF2 DNAJC3 DMTN | 1.11e-05 | 198 | 201 | 10 | 2898_DN |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | USP34 PGPEP1 NEB ITPR2 NEK1 ABCD1 PDE4DIP ZNF350 CCDC9 EPHA1 | 1.11e-05 | 198 | 201 | 10 | 3424_DN |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A | MYCL PGPEP1 EFCAB14 CACTIN HSPA2 NOTCH2 ADGRL1 LMNB2 WDR19 CNNM4 | 1.16e-05 | 199 | 201 | 10 | 5539_DN |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; MCF7; HT_HG-U133A | ITPR2 ABCD1 NOTCH2 VCPIP1 CUL2 SLC26A2 BICRA SIK3 PDE4DIP CCDC9 | 1.16e-05 | 199 | 201 | 10 | 2769_DN |
| Drug | Methamphetamine | CDR2 PDE6C ERCC6 PDE1B ITGA1 ADCY6 ITPR2 DST AP1B1 NFKB1 EXOC7 HSPA1A KIF17 HSPA8 ZMYND12 CUL2 DPYSL2 DPYSL3 RALGAPA2 LZIC DNAH1 KIF20A NRBP2 PDE4DIP ARHGEF2 MAPK11 ENO2 DNAJC3 MYBPC3 | 1.65e-05 | 1401 | 201 | 29 | ctd:D008694 |
| Drug | TGQA | 2.31e-05 | 7 | 201 | 3 | CID000127406 | |
| Drug | Thiostrepton | 3.33e-05 | 42 | 201 | 5 | ctd:D013883 | |
| Drug | 5'-pCAGT-3' | 3.33e-05 | 42 | 201 | 5 | CID000482144 | |
| Drug | Cocaine | ATRX NEB HCN2 ITPR1 JAK1 NEFL AP2B1 NFKB1 HSPA1A HSPA1B SLC25A23 TARS1 CUL4B ROCK2 DPYSL2 DPYSL3 ADGRL1 CNKSR2 TFRC PDE4DIP RAI14 EIF3B ATM MAPK11 ENO2 ATP5F1A EPHA1 | 3.79e-05 | 1314 | 201 | 27 | ctd:D003042 |
| Drug | NSC625381 | 4.55e-05 | 145 | 201 | 8 | CID000002592 | |
| Drug | wortmannin; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 4.85e-05 | 189 | 201 | 9 | 911_UP | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 5.26e-05 | 191 | 201 | 9 | 5296_UP | |
| Drug | butyrate | PGPEP1 ADCY6 IQGAP1 NFKB1 GLUL HSPA2 HSPA8 KRT12 KRT81 KRT83 KRT85 KRT86 POLG SIN3A TFRC WDR19 FCF1 ENO2 MYBPC3 | 5.33e-05 | 767 | 201 | 19 | CID000000264 |
| Drug | bisdesethylchloroquine | 5.48e-05 | 9 | 201 | 3 | CID000122672 | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; HL60; HT_HG-U133A | 5.70e-05 | 193 | 201 | 9 | 2567_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 5.70e-05 | 193 | 201 | 9 | 4410_DN | |
| Drug | Pesticides | 5.79e-05 | 150 | 201 | 8 | ctd:D010575 | |
| Drug | Chloroprene | MYCL ATRX RASL12 GIMAP7 RB1CC1 NEK1 GLUL SLBP FGR HSPA1A CCDC89 HSPA1B HSPA2 HSPA8 FKBP5 ZMYND12 DPYSL3 KRT85 DNAH2 TEAD3 ARHGAP4 AKAP9 HMCN1 TET1 TMF1 ACAP2 LRRC23 | 5.86e-05 | 1348 | 201 | 27 | ctd:D002737 |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.18e-05 | 195 | 201 | 9 | 6868_DN | |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 6.18e-05 | 195 | 201 | 9 | 2867_DN | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 6.18e-05 | 195 | 201 | 9 | 2313_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 6.18e-05 | 195 | 201 | 9 | 3237_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 6.18e-05 | 195 | 201 | 9 | 1649_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 6.42e-05 | 196 | 201 | 9 | 5521_DN | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.42e-05 | 196 | 201 | 9 | 6596_DN | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 6.42e-05 | 196 | 201 | 9 | 2844_DN | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 6.68e-05 | 197 | 201 | 9 | 6471_UP | |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 6.68e-05 | 197 | 201 | 9 | 3220_DN | |
| Drug | Scoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 6.68e-05 | 197 | 201 | 9 | 5536_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; PC3; HT_HG-U133A | 6.68e-05 | 197 | 201 | 9 | 1799_DN | |
| Drug | Omeprazole [73590-58-6]; Down 200; 11.6uM; PC3; HT_HG-U133A | 6.95e-05 | 198 | 201 | 9 | 6606_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 6.95e-05 | 198 | 201 | 9 | 7174_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 6.95e-05 | 198 | 201 | 9 | 2767_DN | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; HL60; HT_HG-U133A | 6.95e-05 | 198 | 201 | 9 | 2334_DN | |
| Drug | Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A | EFCAB14 CACTIN VCPIP1 IFT74 BICRA PDE4DIP ZNF350 MAPK11 ENO2 | 7.22e-05 | 199 | 201 | 9 | 2754_DN |
| Drug | melicopicine | 7.76e-05 | 2 | 201 | 2 | CID000101253 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 7.76e-05 | 2 | 201 | 2 | DB07768 | |
| Drug | tebuquine | 7.76e-05 | 2 | 201 | 2 | CID000071991 | |
| Drug | 3,5-di-O-galloylquinic acid | 7.76e-05 | 2 | 201 | 2 | CID000460896 | |
| Drug | nocodazole | GPHN MYH4 MAN2A1 RB1CC1 IQGAP1 ITPR1 EXOC7 ROCK2 LMNB2 TFRC ARHGAP4 AKAP9 MAP1S ARHGEF2 | 9.32e-05 | 477 | 201 | 14 | CID000004122 |
| Drug | Clorocruoro Hem | 1.13e-04 | 123 | 201 | 7 | CID003518809 | |
| Drug | CuCl2 | 1.14e-04 | 54 | 201 | 5 | CID000024014 | |
| Drug | Clorgyline | 1.28e-04 | 168 | 201 | 8 | ctd:D003010 | |
| Disease | MONILETHRIX | 2.76e-07 | 3 | 193 | 3 | 158000 | |
| Disease | Beaded hair | 2.76e-07 | 3 | 193 | 3 | cv:C0546966 | |
| Disease | monilethrix (is_implicated_in) | 2.76e-07 | 3 | 193 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 1.10e-06 | 4 | 193 | 3 | C0546966 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 2.73e-06 | 5 | 193 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | progeria (implicated_via_orthology) | 1.51e-05 | 8 | 193 | 3 | DOID:3911 (implicated_via_orthology) | |
| Disease | Major depression, single episode | 2.25e-05 | 9 | 193 | 3 | C0024517 | |
| Disease | serum gamma-glutamyl transferase measurement | STAG1 ATRX IRAK1 PGPEP1 ITGA1 ITPR1 SLBP ABCD1 FKBP5 VPS37D NOTCH2 BICRA MAP1S ARHGEF2 SRSF9 DMTN EPHA1 PLCE1 | 3.46e-05 | 914 | 193 | 18 | EFO_0004532 |
| Disease | Hypoxic Brain Damage | 4.26e-05 | 2 | 193 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 4.26e-05 | 2 | 193 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 4.26e-05 | 2 | 193 | 2 | C1527348 | |
| Disease | Anoxia of brain | 4.26e-05 | 2 | 193 | 2 | C0995195 | |
| Disease | hair disease (is_implicated_in) | 4.26e-05 | 2 | 193 | 2 | DOID:421 (is_implicated_in) | |
| Disease | Neoplasms, Hormone-Dependent | 1.27e-04 | 3 | 193 | 2 | C0027661 | |
| Disease | major depressive disorder (is_implicated_in) | 1.75e-04 | 17 | 193 | 3 | DOID:1470 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | ERCC6 RB1CC1 NME8 APOBEC3A RGL1 NAA25 HSPA1B NOTCH2 JAKMIP3 SIK3 THOC5 TFRC CNNM4 AKAP9 FARP1 EIF4A2 TENM1 ATM | 2.60e-04 | 1074 | 193 | 18 | C0006142 |
| Disease | Hermaphroditism | 4.20e-04 | 5 | 193 | 2 | C0019269 | |
| Disease | Ambiguous Genitalia | 4.20e-04 | 5 | 193 | 2 | C0266362 | |
| Disease | Pseudohermaphroditism | 4.20e-04 | 5 | 193 | 2 | C0033804 | |
| Disease | response to bevacizumab, Proteinuria | 4.20e-04 | 5 | 193 | 2 | EFO_0005943, HP_0000093 | |
| Disease | Intersex Conditions | 4.20e-04 | 5 | 193 | 2 | C2930618 | |
| Disease | Sex Differentiation Disorders | 4.20e-04 | 5 | 193 | 2 | C2930619 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 6.04e-04 | 157 | 193 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | retinal vasculature measurement | ITGA1 RB1CC1 ITPR1 RGL1 SCN7A GLUL IQSEC1 TACC3 DNAH5 NIBAN2 PLCE1 | 6.39e-04 | 517 | 193 | 11 | EFO_0010554 |
| Disease | neuroimaging measurement | STAG1 PGPEP1 GINS1 JAK1 NEFL SNX31 TACC3 DPYSL2 RRAS2 DPYSL3 CNKSR2 TFRC COPS4 MAPK6 PCCA DMTN PLCE1 | 6.96e-04 | 1069 | 193 | 17 | EFO_0004346 |
| Disease | phosphatidylcholine 38:4 measurement | 8.00e-04 | 28 | 193 | 3 | EFO_0010386 | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 8.75e-04 | 7 | 193 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | Disorders of Sex Development | 8.75e-04 | 7 | 193 | 2 | C0036875 | |
| Disease | Myopathies, Nemaline | 1.16e-03 | 8 | 193 | 2 | C0206157 | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 1.19e-03 | 32 | 193 | 3 | DOID:332 (is_implicated_in) | |
| Disease | Drug Allergy | 1.55e-03 | 35 | 193 | 3 | C0013182 | |
| Disease | Parkinson's disease (is_implicated_in) | 1.58e-03 | 76 | 193 | 4 | DOID:14330 (is_implicated_in) | |
| Disease | Primary ciliary dyskinesia | 1.68e-03 | 36 | 193 | 3 | cv:C0008780 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.82e-03 | 37 | 193 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | glucagon-like peptide-1 measurement | 1.85e-03 | 10 | 193 | 2 | EFO_0008465 | |
| Disease | cancer (implicated_via_orthology) | 2.00e-03 | 268 | 193 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | senile cataract (is_implicated_in) | 2.25e-03 | 11 | 193 | 2 | DOID:9669 (is_implicated_in) | |
| Disease | vascular dementia (is_marker_for) | 2.25e-03 | 11 | 193 | 2 | DOID:8725 (is_marker_for) | |
| Disease | glycerophosphorylcholine measurement | 2.25e-03 | 11 | 193 | 2 | EFO_0020018 | |
| Disease | Neoplastic Cell Transformation | 2.25e-03 | 139 | 193 | 5 | C0007621 | |
| Disease | Bladder Neoplasm | 2.32e-03 | 140 | 193 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.40e-03 | 141 | 193 | 5 | C0005684 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.69e-03 | 12 | 193 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Kawasaki disease (is_implicated_in) | 2.69e-03 | 12 | 193 | 2 | DOID:13378 (is_implicated_in) | |
| Disease | Paranoid Schizophrenia | 3.17e-03 | 13 | 193 | 2 | C0036349 | |
| Disease | urinary bladder carcinoma | 3.62e-03 | 47 | 193 | 3 | MONDO_0004986 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.68e-03 | 14 | 193 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | reticulocyte count | USP34 USE1 ITGA1 RGL1 AP1B1 AP2B1 NFKB1 VPS37D RRAS2 TFRC NT5DC2 RAI14 ACAP2 EIF2AK2 SRSF9 | 3.79e-03 | 1045 | 193 | 15 | EFO_0007986 |
| Disease | reticulocyte measurement | GPHN USP34 USE1 ITGA1 RGL1 AP1B1 AP2B1 STMN3 NFKB1 RRAS2 TFRC RAI14 ACAP2 EIF2AK2 SRSF9 | 4.06e-03 | 1053 | 193 | 15 | EFO_0010700 |
| Disease | relapsing-remitting multiple sclerosis (is_marker_for) | 4.23e-03 | 15 | 193 | 2 | DOID:2378 (is_marker_for) | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 4.23e-03 | 15 | 193 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 4.23e-03 | 15 | 193 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 4.23e-03 | 15 | 193 | 2 | C0154091 | |
| Disease | Psychotic Disorders | 4.42e-03 | 101 | 193 | 4 | C0033975 | |
| Disease | HIV Infections | 4.74e-03 | 103 | 193 | 4 | C0019693 | |
| Disease | HIV Coinfection | 4.74e-03 | 103 | 193 | 4 | C4505456 | |
| Disease | response to methotrexate | 4.81e-03 | 16 | 193 | 2 | GO_0031427 | |
| Disease | Major Depressive Disorder | 5.43e-03 | 243 | 193 | 6 | C1269683 | |
| Disease | Schizophrenia | RB1CC1 NEFL GLUL SNX31 MCAT HSPA1A HSPA1B KIF17 HSPA1L CACNA1F TET1 ATM ENO2 | 5.59e-03 | 883 | 193 | 13 | C0036341 |
| Disease | Ciliopathies | 5.98e-03 | 110 | 193 | 4 | C4277690 | |
| Disease | Age-related macular degeneration | 6.08e-03 | 18 | 193 | 2 | cv:C0242383 | |
| Disease | Carcinoma of bladder | 6.08e-03 | 18 | 193 | 2 | C0699885 | |
| Disease | interleukin-6 measurement | 6.36e-03 | 112 | 193 | 4 | EFO_0004810 | |
| Disease | Liver carcinoma | 6.41e-03 | 507 | 193 | 9 | C2239176 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SNQEVMKSIEDGYRL | 831 | P21709 | |
| GQVNDRDYMERNKID | 276 | Q86TW2 | |
| VYKLDLEGQRLQGIM | 3426 | Q99996 | |
| DYEGQAKKLLELMEN | 101 | Q53H12 | |
| ELYMEQKNERLELRG | 766 | P55884 | |
| MQEAEKLKAQGEYSR | 106 | Q8N998 | |
| IAKRNVEGQDMLYQS | 876 | P63010 | |
| EYIDGDEKNLMRERI | 271 | Q6UX04 | |
| YGGTNEIMKELIARE | 411 | P28330 | |
| TGEKEEMEELQAYNR | 931 | O43306 | |
| RKTINQGQEDEMEIY | 6 | Q9H7F0 | |
| YKEALQMLRDAGAQV | 136 | P31941 | |
| IMVENANYGRTDDKI | 56 | O94910 | |
| LEKGARLQEIYNRMD | 436 | Q92974 | |
| YMEDGLIKQIGDNLI | 36 | Q14195 | |
| ELMNKYVGESERAVR | 696 | Q8NB90 | |
| GERYKNVNIMILDDD | 3021 | Q8WXG9 | |
| AKRNVEGQDMLYQSL | 886 | Q10567 | |
| YEKLNAGEQRLMNEA | 26 | Q86W34 | |
| AGRQMIDNSYQVEKL | 186 | Q15782 | |
| LDRYPKDIQEMLVQN | 476 | Q9H9F9 | |
| YMKDLGAQLDRLVVD | 216 | Q15057 | |
| KLEYNVDAANGIVME | 256 | Q15057 | |
| NALKDRAEAYLIEEM | 341 | Q13217 | |
| KEVDYSGLRVQAMQI | 91 | Q9UKY7 | |
| KYNQLMRIEEELGDE | 406 | P09104 | |
| LVGYQRQNDLKLEGM | 281 | O75071 | |
| DSKEVYRILNGEMQI | 781 | Q03468 | |
| GTMKLELAQYREVAA | 431 | P25705 | |
| DLLQLQYEGVAVMKL | 1621 | P46940 | |
| LDMAQYRQVTKAEGV | 136 | Q9NYN1 | |
| LYAVQGQMDEDVQKV | 951 | Q9P0K7 | |
| QLLRKADGVVLMYDI | 901 | Q7Z6P3 | |
| IIRISVEDNNGNMYK | 651 | Q9NZL6 | |
| NKLRQEGSEEGMYVL | 451 | P23458 | |
| MGRVLAQDVYAKDNL | 351 | Q9NQX3 | |
| RELVDVMKNAYNQGL | 2071 | Q14571 | |
| YEKMESLRLDGLQQR | 406 | Q96TA1 | |
| MQRKGYSEQDLEAIL | 566 | P33897 | |
| NQNMKAIKGLEDRLY | 356 | Q8TDY2 | |
| AIKGLEDRLYALDQM | 361 | Q8TDY2 | |
| QREKQQMEEDLRGYL | 391 | O60840 | |
| YASEEEIGQLVKQML | 311 | P06132 | |
| LEKMQREEQCILYLG | 206 | Q13451 | |
| NLRIKRDSQGELMVY | 1576 | Q04721 | |
| DREAQELYILKVMAV | 1061 | Q96JQ0 | |
| GGAYMLQKLIEETDR | 1531 | Q14667 | |
| SDYIDQLKRIMEVVG | 226 | Q15759 | |
| MELDKFLEDVRNGIY | 366 | Q9NSY0 | |
| YVISGQDQRKEEGMR | 976 | Q66K74 | |
| DLMVGKLERDLYTQQ | 116 | Q8WZA0 | |
| KMKVLEYIANANGRD | 396 | P43364 | |
| RDESVNKMNIGNEYK | 236 | Q4G0Z9 | |
| MKYENELALRQGVEA | 216 | Q99456 | |
| DGRQYVIKEINISRM | 26 | Q96PY6 | |
| NIVDIRKVYNREIAM | 866 | Q16706 | |
| LLGMRVNNVYDVDNK | 21 | O60524 | |
| GMNKREVLEQVEQGY | 461 | P09769 | |
| MQKQIGYDVLAEDTI | 581 | Q14643 | |
| YQEVMNSKLGLDIEI | 406 | P78386 | |
| YMEDGLIKQIGENLI | 36 | Q16555 | |
| RINEYALEMEDGLNK | 716 | Q13201 | |
| EGLEKMVAEDNERYR | 5796 | Q03001 | |
| KLEEAMQAAVQYQDG | 6261 | Q03001 | |
| MEINAYRKLLEGEEE | 386 | Q03252 | |
| LQDKQVEMLERKYGG | 116 | Q6DN90 | |
| IREYQEVMNSKLGLD | 386 | O43790 | |
| LDAMVVNIGVKVLYE | 1541 | Q8IVV2 | |
| VLVQVYEGERAMTKD | 441 | P54652 | |
| YLAQNMLKKVEGLED | 206 | Q53EV4 | |
| QVYEGERAMTKDNNL | 441 | P0DMV9 | |
| EKGMANLAQLEALYQ | 576 | Q16659 | |
| EMLDLLEQSEGKINY | 191 | Q9NXJ5 | |
| YMVKQLENGEINIEE | 41 | Q01064 | |
| MGEINQVAVEKYLEE | 1 | P51160 | |
| GQLDLYVNIAKQDIM | 196 | P41247 | |
| KMYLDRIIRGNQLQE | 266 | Q9BT78 | |
| INGMAKDQDLLEIVY | 156 | O95843 | |
| AEAQGTYEELQREMK | 446 | P54098 | |
| YLEVEAEAKMENLRA | 696 | P54098 | |
| DVVYRGDMLLEKIQS | 106 | Q13503 | |
| MLYDALQQEAGAKVA | 746 | Q5VZ66 | |
| LIQVYEGERAMTKDN | 441 | P34931 | |
| DLRKEIMIGLQYQAE | 171 | Q7Z3K6 | |
| DGDIYNIVRNMGLKV | 646 | Q6IE36 | |
| GLDLVQEMIRVAKGY | 366 | P05165 | |
| EALKRMADALDNYVI | 461 | P05165 | |
| IIYRMEDGNIKILQT | 466 | P56199 | |
| RQKMVQKLALYEDGA | 666 | P51617 | |
| GMNYDQEKEIIEVIL | 1551 | Q2PPJ7 | |
| RNGADYRDMILKQVV | 1471 | Q7Z6Z7 | |
| IKYGVEQVGDMIDRL | 716 | Q9UPT5 | |
| KDQIQDVEGRYMQGL | 351 | Q9Y608 | |
| KLEIMSAQEIDRGQY | 1696 | Q96RW7 | |
| KEIQSVYIREGMGQL | 386 | Q9BRQ0 | |
| GLYAVKIRAEAMQEA | 171 | Q8IVS2 | |
| AGKVIVELMAYENAN | 471 | P87889 | |
| LREVEDGIATMQAKY | 3081 | Q9P2D7 | |
| IMQTYLEKAVEVAGN | 2356 | Q13315 | |
| LAQGTMEDKIYDRQV | 2166 | P46100 | |
| RYLMNEEQAVSKVDG | 261 | Q8NFZ0 | |
| VEIKELQGQLADYNM | 141 | Q96LB3 | |
| LQGQLADYNMLVDKL | 146 | Q96LB3 | |
| KNNIEKYREGQEALM | 671 | P0C221 | |
| VQKGLNDTMRYILID | 301 | P41002 | |
| MEELNTYRQKQGVVL | 11 | P19525 | |
| RVTMEEEYGLVLKEN | 216 | Q01850 | |
| QIRDYQRIGDVMLKN | 616 | Q9Y4F1 | |
| VMAEIEKLGQKYRVA | 106 | Q9Y324 | |
| MEKIAEYERNQREGV | 171 | Q9Y3X0 | |
| LDADKNEDLGRMYNL | 311 | Q13616 | |
| MLEKQRNLYIGSAND | 681 | Q14CM0 | |
| LRSAGVEQLMYIKED | 241 | Q14320 | |
| AMALKAVGEIIQDYD | 331 | Q8IYJ1 | |
| AVDEDRKMYLQAAIV | 671 | Q13617 | |
| DEMLSRGFKDQIYEI | 186 | Q14240 | |
| IIRVSLDVDNGNMYK | 801 | Q12967 | |
| IDYDLKAAMQEARGL | 176 | Q9Y2E5 | |
| ENMQIRTKVAGIYRE | 111 | Q5PSV4 | |
| EDIQVYMELEQGKNA | 346 | Q8WUQ7 | |
| KYNQLMRIEEALGDK | 406 | P13929 | |
| QVYEGERAMTKDNNL | 441 | P0DMV8 | |
| QTREAVKQMDVIVGY | 3361 | Q8NDH2 | |
| PNMDREAKDQYLLVI | 216 | Q9ULB5 | |
| KAAIEREYAQGMQKL | 46 | O94868 | |
| DTIKRYNLQMLEAEG | 451 | Q8NFF5 | |
| ELAAVEDELYQRMLK | 1431 | Q9NZM4 | |
| VAKMDNQVLGYKDLA | 31 | Q08495 | |
| YGKLRETVEQEIRDM | 2041 | Q9P225 | |
| LLMRIGDKEVEYNTN | 3466 | Q9P225 | |
| KYDREMVQQAELGQR | 696 | Q9UL51 | |
| EETNRLYAAEGQKLM | 391 | Q13620 | |
| LYAAEGQKLMQEREV | 396 | Q13620 | |
| YAQIERLMEQGTKIR | 201 | B7ZC32 | |
| LMEDLKVLYRTAGQQ | 2991 | Q8TE73 | |
| IREYQEVMNSKLGLD | 391 | P78385 | |
| QVYEGERAMTKDNNL | 441 | P11142 | |
| EAVLQVGVLYKAEVM | 461 | Q9P2E2 | |
| DQEVLKDQNYVEIMG | 61 | Q13416 | |
| MREENGLKYIEEAIE | 261 | P15104 | |
| EGKADMETLQRIYGI | 286 | P26639 | |
| GKNYMKQRDDILINR | 341 | Q8TED0 | |
| ELGKIMDRFEEVVYQ | 671 | Q9Y6A5 | |
| DVQKDGVGMVEYLRK | 141 | Q13242 | |
| DESVLMRRQKQINYG | 131 | Q14493 | |
| EEDAQKAYIMGLLDR | 101 | Q9ULQ0 | |
| QRVGLAVDMDEIEKY | 631 | Q3BBV2 | |
| QRVGLAVDMDEIEKY | 666 | P0DPF3 | |
| QRVGLAIDMDEIEKY | 666 | Q6P3W6 | |
| QRIGLAVDMDEIEKY | 666 | Q86T75 | |
| QRVGLAVDMDEIEKY | 1181 | Q5TAG4 | |
| QRVGLAVNMDEIEKY | 326 | Q5TI25 | |
| RVGLAVDMDEIEKYQ | 571 | Q5TI25 | |
| RVGLAVDMDEIEKYQ | 646 | Q5TI25 | |
| RVGLAIDMDEIEKYQ | 396 | Q8N660 | |
| RVGLAIDMDEIEKYQ | 396 | A0A087WUL8 | |
| QRIGLAVDMDEIEKY | 51 | P0DPF2 | |
| RVGLAVDMDEIEKYQ | 296 | P0DPF2 | |
| QRVGLAVDMDEIEKY | 1271 | P0DPF2 | |
| RVGLAVDMDEIEKYQ | 1516 | P0DPF2 | |
| QRVGLAVDMDEIEKY | 2491 | P0DPF2 | |
| RVGLAVDMDEIEKYQ | 2736 | P0DPF2 | |
| QRVGLAVDMDEIEKY | 3711 | P0DPF2 | |
| RVGLAVDMDEIEKYQ | 3956 | P0DPF2 | |
| QRVGLAVDMDEIEKY | 4931 | P0DPF2 | |
| QRVGLAVDMDEIEKY | 326 | B4DH59 | |
| QRVGLAVDMDEIEKY | 401 | B4DH59 | |
| QRVGLAVDMDEIEKY | 476 | B4DH59 | |
| QRVGLAVDMDEIEKY | 551 | B4DH59 | |
| QRVGLAVDMDEIEKY | 626 | B4DH59 | |
| EGYMGRIVLKTQQEN | 2101 | Q9P212 | |
| MAKQLQARRLDGIDY | 1 | Q16773 | |
| VELIEKMVQCNEGAY | 186 | Q8NHV1 | |
| NREKMAQELKYGDIV | 436 | O14802 | |
| EGQQLARQLKVTYME | 141 | P62070 | |
| TAAQKLRGMDEVYNL | 871 | Q96ST3 | |
| EQLQKMYGGQIDERT | 656 | Q9Y2K2 | |
| RITRLGEIQYKMDED | 2201 | Q9UKZ4 | |
| YEEEQEAKAELQRGM | 1351 | Q9Y623 | |
| DEQVVMGNKLLVYIS | 716 | Q8N3P4 | |
| IVMSLEQIKGIEDYN | 706 | Q8NEZ3 | |
| NQYRADIKEMGLSLQ | 626 | P02786 | |
| RGLQAEYETQVKEMR | 11 | P98171 | |
| VDLLYMQAIQDIEKG | 221 | Q8N9S9 | |
| QYGDMEVKQLDKRAS | 36 | Q9NZ72 | |
| VAAVREIMENRYGQK | 1446 | Q8NFU7 | |
| EEMKAIDGLNRNVRY | 291 | Q04828 | |
| EEMKAIDGLNRNVRY | 291 | P52895 | |
| MQDEDGYITLNIKTR | 1 | Q9P126 | |
| MLTAGYAERERIKQE | 666 | Q8WXI2 | |
| YNDLVKEELNMIQGA | 351 | Q6P4Q7 | |
| DSGEYKMILVVRNDL | 61 | Q9Y3E5 | |
| RLEKYVGALEDMLQA | 31 | Q9NZ43 | |
| LQMYGEKAEEAEELR | 1056 | P82094 | |
| KIGLIEEAMADYNQA | 496 | Q86TZ1 | |
| DEMLQNKGLTVIDVY | 21 | Q8N427 | |
| RYIEKLTNEMKEAGN | 631 | Q9NXC5 | |
| TYGELQRMQEKERNK | 31 | P12872 | |
| ALEYLQALVGAEKRM | 326 | P12524 | |
| MIGETVDRELQKAGY | 171 | P50443 | |
| NEADISMYGKEELLQ | 551 | O95235 | |
| KVREYQVGIKAMNLD | 101 | Q99594 | |
| MLLKVQNAIGELYLE | 856 | Q6P2S7 | |
| KIRGLQMKAEDYDVV | 81 | O75116 | |
| YEAERNKMIGKRANE | 251 | Q8WVM7 | |
| EVYRGKLIEAEDNMN | 26 | P62318 | |
| MEKRLQEAQLYKEEG | 1 | Q8N5M4 | |
| EMGRAALAIKYQELR | 76 | Q86XT2 | |
| IEQDMEKYILRGDET | 236 | Q9H857 | |
| QDKYLLRLVAAMEEV | 406 | Q96JH7 | |
| MRNYLKERGDQTVLI | 36 | Q06330 | |
| AQEYGMRALSLAKEQ | 326 | Q9H0C1 | |
| GAAQKDLYRDVMLEN | 26 | Q9GZX5 | |
| LQERGLEQMAVIYKE | 36 | Q9UC06 | |
| MAYEQIKRAILGQQE | 261 | Q9BV35 | |
| GILAMAYEEEKQRVG | 391 | Q01118 | |
| DVYNLAERKVEVPQM | 391 | Q5TAH2 | |
| DLLVEMVKGSVENYR | 1846 | Q70CQ2 | |
| DNIRAMEGEVNVCYK | 596 | Q13769 | |
| EDGLRQVLEEMKALY | 26 | Q14691 | |
| IREYQEVMNSKLGLD | 386 | Q14533 | |
| MILERLGKYQEALDV | 201 | Q14CX7 | |
| YQVIEGQNDTMAKLR | 301 | Q5VU43 | |
| GTYQVTVRIENMEDK | 1041 | Q14896 | |
| INYRGIQRKVVEMEQ | 6471 | P20929 | |
| GDMKQLAEDVKLQLY | 806 | P19838 | |
| LNVKMALDIEIAAYR | 376 | P07196 |